Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1050.Time spend outdoors in summer,48398,-0.00722570235212727,0.0198902508346855,-0.0462105939881108,0.0317591892838563,0.716399989240734
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1060.Time spent outdoors in winter,44800,-0.0143544090301616,0.0227520640202981,-0.0589484545099458,0.0302396364496226,0.528109209207013
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X1070.Time spent watching television (TV),49925,0.0981770990136649,0.0201969606679017,0.0585910561045776,0.137763141922752,1.17498839496506e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X1080.Time spent using computer,44728,-0.0715985957791682,0.0215299729336303,-0.113797342729084,-0.0293998488292528,0.000884068626778604
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X1090.Time spent driving,42215,0.0178363438391808,0.0231334481748573,-0.0275052145835396,0.0631779022619011,0.440705521922199
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1160.Sleep duration,51427,0.0274298775927585,0.0182307933192917,-0.00830247731305327,0.0631622324985702,0.132441110447858
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,33900,0.00397218205864068,0.0207153818951948,-0.0366299664559412,0.0445743305732226,0.847941872313889
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,33900,0.0462863516278744,0.0186067141113388,0.00981719196965043,0.0827555112860984,0.0128773782379759
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,33900,-0.00167635431750725,0.0222635158911403,-0.0453128454641422,0.0419601368291277,0.93998077580852
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,33900,0.0110757515260096,0.0227750118927165,-0.0335632717837147,0.0557147748357339,0.626757564879771
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,33900,0.0204558856181753,0.0231184799485576,-0.0248563350809976,0.0657681063173483,0.376271753464891
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,33900,-0.00879743188349361,0.0441919024771384,-0.0954135607386849,0.0778186969716977,0.842209619202292
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,33900,-0.0290910845202696,0.0443006326232216,-0.115920324461784,0.0577381554212447,0.511406391401098
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,33900,-0.0281847151766409,0.0338962092382847,-0.0946212852836789,0.0382518549303971,0.405711955516407
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,33900,-0.0359023024696736,0.0243251873671217,-0.083579669709232,0.0117750647698849,0.139995693658317
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,33900,0.023112658668598,0.0167209270535585,-0.00966035835637678,0.0558856756935727,0.166924741058218
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#18.Location of pain during the past week_Upper back,33900,0.01883727139987,0.0232717667765102,-0.02677539148209,0.0644499342818301,0.418278224034065
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#19.Location of pain during the past week_Lower back,33900,0.0130677848317234,0.0142486179328204,-0.0148595063166045,0.0409950759800513,0.359099775385761
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,33900,0.00493997792888491,0.0178078468132399,-0.0299634018250653,0.0398433576828352,0.781475549018811
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,33900,0.0455275226122411,0.0254992111319366,-0.00445093120635472,0.0955059764308369,0.0742207002028533
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,33900,0.0254900249302384,0.0243572051948677,-0.0222500972517024,0.0732301471121791,0.295353044012084
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,33900,-0.0205726529324339,0.0341107037117532,-0.0874296322074702,0.0462843263426024,0.546447136093001
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,33900,-0.0700009170283121,0.0314423726100683,-0.131627967344046,-0.00837386671257827,0.0260159592539857
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#7.Location of pain during the past week_Left hip,33900,0.0133518268570517,0.0190080174003655,-0.0239038872476648,0.0506075409617681,0.482427520419897
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#8.Location of pain during the past week_Right hip,33900,0.0213784523880117,0.017841397394011,-0.0135906865042499,0.0563475912802733,0.230849806291538
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,33900,0.0201823500688693,0.0236767260680922,-0.0262240330245915,0.0665887331623301,0.394006491511819
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120040.Fatigue severity over the past week,33906,0.070066066322658,0.0323010536655127,0.00675600113825309,0.133376131507063,0.0300955885339296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120041.Waking unrefreshed severity over the past week,33903,0.0718881037197588,0.0320593508362821,0.0090517760806459,0.134724431358872,0.0249622255040583
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120042.Cognitive symptoms severity over the past week,33903,0.0944485743028634,0.034066309414655,0.0276786078501396,0.161218540755587,0.00557378278993389
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120098.Mobility problems today,33910,0.0637307042999184,0.037877531000482,-0.0105092564610264,0.137970665060863,0.092495949209377
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120099.Self-care problems today,33910,0.0302546812928759,0.0597484829467557,-0.0868523452827653,0.147361707868517,0.612610593715034
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120100.Problems doing usual activities,33910,0.0435544371696407,0.0358149533293339,-0.0266428713558538,0.113751745695135,0.223978546800572
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120101.Pain or discomfort today,33910,0.0739524127270529,0.0323297014581116,0.010586197869154,0.137318627584952,0.0221918474453398
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120102.Anxiety or depression today,33910,0.0445171858794157,0.0376285892289008,-0.0292348490092298,0.118269220768061,0.236811881153673
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120103.Scale to indicate how health is today,33874,-0.00651890185012024,0.00614794908377648,-0.0185688820543221,0.00553107835408167,0.289018198863427
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,33886,0.047277999711554,0.038819008915895,-0.0288072577636002,0.123363257186708,0.22328922342493
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",33862,0.0157363391637617,0.0391308065332476,-0.0609600416414035,0.092432719968927,0.687584929690558
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",33892,0.0704394076380377,0.0316442623209332,0.00841665348900853,0.132462161787067,0.0260392292242344
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,33886,0.0845164993565887,0.0326629133846,0.0204971891227728,0.148535809590405,0.00968129255412211
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,33896,0.0930890085670521,0.0391058750435479,0.0164414934816982,0.169736523652406,0.0173119174852192
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120109.Feeling bad about self over the last two weeks,33867,0.0504676902352809,0.0405722566220252,-0.0290539327438885,0.12998931321445,0.213568612615217
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120110.Trouble concentrating over the last two weeks,33891,0.0585162467276504,0.041879361707144,-0.0235673022183519,0.140599795673653,0.162369040626951
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,33883,0.169926432670949,0.0597728184620301,0.0527717084853704,0.287081156856528,0.00448051896105339
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,33844,0.0857846993453433,0.0821050953590537,-0.075141287558402,0.246710686249089,0.29613501541008
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31569,0.0687576119188038,0.0428517393488562,-0.0152317972049543,0.152747021042562,0.108638007780248
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49116,0.0675799502370016,0.043640793688025,-0.0179560053915273,0.153115905865531,0.121502768925692
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47301,0.0380276191353757,0.0287919794907784,-0.01840466066655,0.0944598989373014,0.18659087252391
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1289.Cooked vegetable intake,50904,-0.0306444547594556,0.0190621564245928,-0.0680062813516576,0.00671737183274627,0.107933229008129
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50419,-0.113777566497164,0.0202626610716433,-0.153492382197585,-0.0740627507967435,1.9841568967437e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1309.Fresh fruit intake,50952,0.0327171558235983,0.0197382034121346,-0.0059697228641855,0.071404034511382,0.0974191758614969
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1319.Dried fruit intake,49224,-0.0209826329885197,0.019878116961574,-0.0599437422332047,0.0179784762561654,0.291177558551381
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X134.Number of self-reported cancers,51711,-0.0164060236390966,0.0328755294293226,-0.0808420613205688,0.0480300140423757,0.61775910187169
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X135.Number of self-reported non-cancer illnesses,51711,0.0798857344682147,0.0189002497837457,0.0428412448920731,0.116930224044356,2.37912087119501e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X136.Number of operations, self-reported",51711,-0.00697608157618278,0.0191322426041049,-0.0444752770802283,0.0305231139278627,0.715394662338745
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X137.Number of treatments or medications taken,51711,0.121221510880785,0.0186861492469412,0.0845966583567802,0.15784636340479,8.89218464024683e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1438.Bread intake,50776,0.00494923063148659,0.00410960067233742,-0.00310558668629475,0.0130040479492679,0.228480851201178
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1458.Cereal intake,50335,0.0843624967856291,0.0188785767835241,0.0473604862899219,0.121364507281336,7.90337895936719e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1488.Tea intake,50806,0.00471639674790889,0.00384244013831702,-0.00281478592319248,0.0122475794190103,0.219665093026816
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1498.Coffee intake,49548,-0.0193290615926078,0.0190739938225548,-0.0567140894848153,0.0180559662995997,0.310892020099789
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1528.Water intake,50015,-0.0786698505131783,0.0193272189794675,-0.116551199712935,-0.0407885013134221,4.70700033821451e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1568.Average weekly red wine intake,41109,-0.127950886786031,0.0234731393536041,-0.173958239919095,-0.0819435336529666,5.08139181298279e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,41109,-0.128716811008035,0.0234803380985196,-0.174738273681133,-0.0826953483349367,4.26902711617084e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1588.Average weekly beer plus cider intake,41131,0.0444364323072226,0.0293042501668334,-0.012999898019771,0.101872762634216,0.129441784876322
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1598.Average weekly spirits intake,41060,0.0283224555403159,0.026081890891012,-0.0227980506060676,0.0794429616866994,0.277536789753294
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1608.Average weekly fortified wine intake,41136,0.0837351046637193,0.039425150395632,0.00646180988828055,0.161008399439158,0.0336931181236319
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1737.Childhood sunburn occasions,45218,-0.0535261259399813,0.0228180032193975,-0.0982494122500005,-0.00880283962996208,0.0189964202533555
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X1807.Father's age at death,44314,-0.0105502925946794,0.00445300352303007,-0.0192781794998184,-0.0018224056895405,0.0178335553271756
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X1845.Mother's age,35084,0.00326645799768411,0.0099718836078888,-0.0162784338737779,0.0228113498691462,0.743245677758342
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X1873.Number of full brothers,51206,0.0526128142643252,0.0182656149553752,0.0168122089517899,0.0884134195768605,0.0039744920358517
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X1883.Number of full sisters,51211,0.0240042906399538,0.0184439563436092,-0.0121458637935202,0.0601544450734278,0.193108186892167
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X20015.Sitting height,51522,-0.0209211442182629,0.00506823933279005,-0.0308548933105314,-0.0109873951259944,3.67199913586457e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20016.Fluid intelligence score,33197,-0.0684681604636235,0.0305350120793938,-0.128316784139235,-0.0086195367880116,0.0249680360061876
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20018.Prospective memory result,33535,0.017295632382718,0.0404615895669797,-0.0620090831685622,0.0966003479339982,0.669055864193929
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),33070,0.00932915063900859,0.00702193954180693,-0.00443385086293299,0.0230921521409502,0.184024468970858
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),33044,0.0027751436837101,0.00697964003508666,-0.0109049507850598,0.01645523815248,0.69093083899383
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20023.Mean time to correctly identify matches,51404,0.0107303291308124,0.0041610983045127,0.00257457645396749,0.0188860818076573,0.00992181628195515
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#1.Illnesses of father_Heart disease,48516,0.0184444399257133,0.00854757827773131,0.00169118650135991,0.0351976933500666,0.0309489202120938
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48092,0.0295690762722088,0.0185585343937299,-0.00680565113950191,0.0659438036839195,0.111109134405606
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48063,-0.00321485862740164,0.0251724063319429,-0.0525527750380098,0.0461230577832065,0.898376714815875
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#12.Illnesses of father_Severe depression,48076,-0.0365086880146905,0.0204100880244918,-0.0765124605426944,0.00349508451331335,0.0736667657281147
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48082,-0.0159437886298027,0.015261645864122,-0.0458566145234819,0.0139690372638765,0.296173931178609
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#2.Illnesses of father_Stroke,48239,-0.0232829098563805,0.0110832436473945,-0.0450060674052738,-0.00155975230748733,0.0356751128126439
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48179,0.00546085947977768,0.0139440702159316,-0.0218695181434483,0.0327912371030036,0.69533814218247
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48088,-0.0288536503204658,0.0178859304178088,-0.0639100739393711,0.00620277329843943,0.10671359531076
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48236,0.0080199871310361,0.0125587780270276,-0.016595217801938,0.0326351920640102,0.523091844153571
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48290,0.00488434009541475,0.00950909499211001,-0.0137534860891209,0.0235221662799504,0.607501957525918
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#9.Illnesses of father_Diabetes,48168,0.0101575764294795,0.0132669777226511,-0.0158456999069167,0.0361608527658757,0.443904993012468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49886,0.0251089177333988,0.00946795167356844,0.00655173245320467,0.043666103013593,0.00800684300108161
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49761,-0.00101470184116221,0.0138176055362503,-0.0280972086922128,0.0260678050098884,0.941460202826598
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49693,0.00925428954955922,0.0295962683591669,-0.0487543964344079,0.0672629755335264,0.754523079761061
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49730,0.0374208369903978,0.0148741648881142,0.00826747380969395,0.0665742001711017,0.0118814650296463
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#2.Illnesses of mother_Stroke,49823,0.0131387552881244,0.0109287632433265,-0.00828162066879551,0.0345591312450443,0.229290318869833
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49714,-0.00940175590023993,0.020237233184556,-0.0490667329419696,0.0302632211414898,0.642238310289516
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49711,-0.0094573686996104,0.0178764551820933,-0.0444952208565132,0.0255804834572924,0.596782007487644
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49742,0.00143210213282735,0.0142062818326461,-0.0264122102591589,0.0292764145248136,0.919703939320438
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49757,-0.00647249536639946,0.0158882631343768,-0.037613491109778,0.0246685003769791,0.683735376591519
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49913,0.00867149574701488,0.0082382814916367,-0.00747553597659306,0.0248185274706228,0.292540989009471
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49770,0.0674179984342623,0.0129610618698456,0.0420143171693648,0.0928216796991597,1.99138859363496e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46322,0.0154616791154061,0.0134350910392198,-0.0108710993214647,0.0417944575522769,0.249809455062682
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46180,0.0694564212436748,0.0526361364946132,-0.0337104062857671,0.172623248773117,0.186996624242104
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46177,-0.0276382176649591,0.0543847014849358,-0.134232232575433,0.0789557972455152,0.611319380655007
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46241,0.0272924486118151,0.0148505122895527,-0.00181455547570816,0.0563994526993383,0.0661037301559775
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46192,0.0346528153280817,0.0312295086095884,-0.0265570215467116,0.095862652202875,0.267176077003302
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46205,-0.0155194488214789,0.0229862462192218,-0.0605724914111536,0.0295335937681957,0.499579777982193
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46186,0.037279406745092,0.0277963748195982,-0.0172014879013205,0.0917603013915046,0.179882283463485
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46183,0.0147385581883549,0.0271364940640441,-0.0384489701771715,0.0679260865538813,0.58704804673828
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46204,-0.0400873891066542,0.0197066761147993,-0.0787124742916608,-0.0014623039216476,0.0419431907096932
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46206,0.0248802702075784,0.0238124345178641,-0.0217921014474352,0.0715526418625919,0.296106862234669
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46394,0.00848580822571677,0.00991308877398372,-0.0109438457712913,0.0279154622227249,0.391995731328246
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46280,0.0275511876803456,0.0142401081260997,-0.000359424246809788,0.0554617996075009,0.0530326917871653
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20127.Neuroticism score,45869,0.0308074832927744,0.0193614025561161,-0.00714086571721312,0.0687558323027619,0.111583760361444
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,33197,-0.0053644372164284,0.0312503951659763,-0.066615211741742,0.0558863373088852,0.863708952526882
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X20161.Pack years of smoking,31700,0.0708954744273654,0.00840330775034544,0.0544249912366883,0.0873659576180425,3.90471288504417e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31700,0.0688892399732072,0.00829070040958292,0.0526394671704247,0.0851390127759897,1.13965903939116e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20191.Fluid intelligence score,31364,-0.0181770271445379,0.034599833863808,-0.0859927015176014,0.0496386472285257,0.599356696702886
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31364,0.0247703372851045,0.0356495458356612,-0.0451027725527916,0.0946434471230005,0.487185885318948
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20240.Maximum digits remembered correctly,30627,-0.0620209477363429,0.0375871520480884,-0.135691765750596,0.0116498702779104,0.0989821795541741
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X20255.Spirometry QC measure,45422,0.0544145366748345,0.0253952285444632,0.00463988872768672,0.104189184621982,0.0321480995924279
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X20261.avMSE,30394,-0.00290523156569769,0.00795033579375925,-0.0184878897214658,0.0126774265900704,0.714809056552267
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X20262.Myopia diagnosis,30394,0.0487416982155319,0.0460800177756307,-0.0415751366247043,0.139058533055768,0.290206903859448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X20280.Glucose-lactate,39997,0.0155112524714969,0.00515547205545944,0.00540652724279642,0.0256159777001974,0.00262790968819016
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X20281.Spectrometer-corrected alanine,40035,0.0143674424541744,0.00494751201767859,0.00467031889952433,0.0240645660088244,0.00368977047353833
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32988,0.0107009986472624,0.0244032471549612,-0.0371293657764616,0.0585313630709864,0.661029777110226
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32985,-0.0154276390513428,0.0452920383690514,-0.104200034254684,0.073344756151998,0.733393652298131
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32983,-0.0279400413909788,0.0572835705275549,-0.140215839624986,0.0843357568430287,0.625739714310978
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32983,-0.00499546992900484,0.0228547003158908,-0.0497906825481508,0.0397997426901411,0.826986227627392
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32983,-0.0192104410624031,0.045502493235906,-0.108395327804779,0.0699744456799728,0.672901094230813
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32991,-0.0558560278349203,0.0563262279324933,-0.166255434582607,0.0545433789127666,0.321395314893903
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32991,-0.0546845791344962,0.0369005981137585,-0.127009751437463,0.0176405931684705,0.13839239116917
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32991,0.0191269299895672,0.040542138946435,-0.0603356623454454,0.0985895223245799,0.637096592344956
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32991,-0.0498536583257112,0.066304648216389,-0.179810768829834,0.0801034521784113,0.452139238519117
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32991,0.0598502464436334,0.0799826637937738,-0.0969157745921632,0.21661626747943,0.454305720801309
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32991,-0.0286763705214152,0.0418568484094619,-0.11071579340396,0.0533630523611301,0.493295743334428
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32991,-0.0528071542191305,0.0820373319379279,-0.213600324817469,0.107986016379208,0.519789462015638
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32991,-0.00767088505506149,0.0563026975539499,-0.118024172260803,0.10268240215068,0.891631880387697
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32989,0.0580828936189721,0.066667103897252,-0.0725846300196419,0.188750417257586,0.383648883688436
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32989,-0.0129252327040756,0.0309622469705767,-0.0736112367664059,0.0477607713582547,0.676358778326406
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32989,-0.0928192367280484,0.0499243759935143,-0.190671013675336,0.00503254021923955,0.0630336389523569
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32991,0.0274178107667777,0.073269587620965,-0.116190580970314,0.171026202503869,0.708261453891058
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20600.Liking for adding salt to foods,34842,-0.012080218128233,0.0287623861923788,-0.0684544950652955,0.0442940588088295,0.67449374146742
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20601.Liking for aniseed,34842,-0.0303392026472409,0.0282217091616469,-0.0856537526040688,0.0249753473095871,0.282385986522765
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20602.Liking for apple juice,34842,0.0950650757140181,0.0287591272970507,0.0386971862117988,0.151432965216237,0.000951076298760697
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20603.Liking for apples,34842,-0.0247117919181399,0.0292454693250269,-0.0820329117951926,0.0326093279589128,0.398142333663641
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20604.Liking for asparagus,34842,-0.122438127079641,0.0292472628535974,-0.179762762272692,-0.0651134918865903,2.8586409473158e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20605.Liking for aubergine,34842,-0.130073900317274,0.0286374214251882,-0.186203246310643,-0.0739445543239054,5.63258162392292e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20606.Liking for avocados,34842,-0.14820573205607,0.0293958935012441,-0.205821683318508,-0.0905897807936316,4.69165029892231e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20607.Liking for bacon,34842,0.0459588001177257,0.0287370012634091,-0.0103657223585561,0.102283322594008,0.109786601983054
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20608.Liking for baked or steamed fish,34842,-0.0116762738529118,0.0293106321831702,-0.0691251129319253,0.0457725652261018,0.690370757661072
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20609.Liking for bananas,34842,0.102914726556608,0.0300845772831541,0.0439489550816261,0.16188049803159,0.000626669901601495
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20610.Liking for barbequed or grilled meat,34842,-0.04807957754416,0.0284918235074153,-0.103923551618694,0.00776439653037407,0.091539817421732
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20611.Liking for beef steak,34842,-0.0372434393040703,0.0285915952352614,-0.0932829659651827,0.018796087357042,0.192739926938665
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20612.Liking for beetroot,34842,0.00499641476521685,0.0292942230477963,-0.0524202624084639,0.0624130919388976,0.864573288787858
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20613.Liking for bell pepper,34842,-0.0510424214569666,0.0288847900160328,-0.107656609888391,0.00557176697445763,0.0772402274399839
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20614.Liking for bicycling,34842,-0.0781109352041497,0.0287368895876442,-0.134435238795932,-0.0217866316123671,0.00657587289034723
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20615.Liking for biscuits,34842,0.184771232642185,0.0291416746911881,0.127653550247457,0.241888915036914,2.38624639048359e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20616.Liking for bitter foods,34842,-0.106054142024016,0.0285326488599451,-0.161978133789508,-0.0501301502585237,0.000202710303510857
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20617.Liking for bitter or ale,34842,-0.0758792868557085,0.0297839943450125,-0.134255915771933,-0.017502657939484,0.0108593131562084
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20618.Liking for black olives,34842,-0.143804471425241,0.0288161148351669,-0.200284056502168,-0.087324886348314,6.12260281290058e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20619.Liking for black pepper,34842,-0.0555896428262956,0.028696763283256,-0.111835298861477,0.000656013208886197,0.052755349503265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20620.Liking for blue cheese,34842,-0.0614939104152355,0.0288001548859966,-0.117942213991789,-0.00504560683868222,0.0327685295636077
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20621.Liking for bolognese sauce,34842,0.00727726514453116,0.0285826835897307,-0.048744794691341,0.0632993249804033,0.79903402415026
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20622.Liking for broad beans,34842,-0.0607680628127617,0.0286272395179564,-0.116877452267956,-0.00465867335756715,0.0337996086893375
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20623.Liking for broccoli,34842,-0.0390460522613554,0.0298686148592049,-0.097588537385397,0.0194964328626861,0.191153300373824
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20624.Liking for brown rice,34842,0.0069021767422794,0.0287811085864047,-0.0495087960870739,0.0633131495716327,0.810477465022631
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20625.Liking for brussel sprouts,34842,-0.000740253229879489,0.0291386679873089,-0.0578520424850048,0.0563715360252459,0.979732811756113
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20626.Liking for burgers (meat),34842,-0.0491973068790052,0.0286912839377903,-0.105432223397074,0.00703760963906375,0.0864277733943713
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20627.Liking for burn of spicy foods,34842,-0.0781288425366144,0.0287669061900711,-0.134511978669154,-0.021745706404075,0.00661997182514137
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20628.Liking for butter on bread,34842,0.0625954310016067,0.0295111755899106,0.00475352684538193,0.120437335157831,0.0339390868299197
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20629.Liking for butternut squash,34842,-0.0925915302303863,0.0287210314080413,-0.148884751790147,-0.0362983086706254,0.00126882466990931
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20630.Liking for cabbage,34842,-0.0263916059017547,0.0291148009832045,-0.0834566158288355,0.030673404025326,0.364709770483082
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20631.Liking for cake,34842,0.128326217173834,0.0289632542406407,0.0715582388621784,0.18509419548549,9.49096679558138e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20632.Liking for cake icing,34842,0.162839928073004,0.0285575539454051,0.10686712234001,0.218812733805998,1.21525726504578e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20633.Liking for capers,34842,-0.170649939404935,0.0286694733895997,-0.226842107248551,-0.11445777156132,2.72918891986361e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20634.Liking for cauliflower,34842,0.0117718326066226,0.0294080658940643,-0.0458679765457435,0.0694116417589886,0.688949218322715
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20635.Liking for cereal or granola bar,34842,0.0979601523947268,0.0287201992682715,0.0416685618289147,0.154251742960539,0.000650086284214946
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20636.Liking for cheesecake,34842,0.156743996791275,0.0287541512777298,0.100385860286925,0.213102133295626,5.11827454903727e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20637.Liking for cherries,34842,-0.0111277922499366,0.0312737892003058,-0.0724244190825361,0.0501688345826628,0.721983735990765
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20638.Liking for chicken,34842,0.00641400730082263,0.0303806244192363,-0.0531320165608805,0.0659600311625257,0.832796497326579
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20639.Liking for chilli pepper,34842,-0.124163591110567,0.028508515456338,-0.180040281404989,-0.0682869008161442,1.34150268465691e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20640.Liking for chips or french fries,34842,0.0388350817420831,0.0288069738206179,-0.017626586946328,0.0952967504304942,0.177651166795035
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20641.Liking for cigarette smoking,34842,0.0240041174582592,0.0477698826907782,-0.0696248526156661,0.117633087532185,0.61533017104195
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20642.Liking for cod,34842,-0.0025985488803203,0.0295417499192261,-0.0605003787220034,0.0553032809613628,0.929908643269882
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20643.Liking for coffee with sugar,34842,0.108310772940779,0.0328143265373669,0.0439946929275404,0.172626852954018,0.000967637429793985
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20644.Liking for coffee without sugar,34842,-0.109210191722302,0.0293721444075968,-0.166779594761191,-0.051640788683412,0.000201739120441036
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20645.Liking for coriander,34842,-0.116171978645099,0.028499939973083,-0.172031860992342,-0.0603120962978563,4.61151775234977e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20646.Liking for corn flakes,34842,0.201205127164381,0.0286240918938857,0.145101907052365,0.257308347276397,2.20741413086611e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20647.Liking for cream,34842,0.0622109762591425,0.0285532890629805,0.00624652969570071,0.118175422822584,0.0293713642506659
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20648.Liking for croissant,34842,0.0559969351055447,0.028684852433794,-0.000225375664691572,0.112219245875781,0.050948069783565
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20649.Liking for cucumber,34842,-0.0259155771839737,0.0288265393177196,-0.0824155942467041,0.0305844398787567,0.368663935059829
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20650.Liking for curry,34842,-0.0957296576430228,0.0288594877270951,-0.152294253588129,-0.0391650616979165,0.000912712329691351
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20651.Liking for dairy products,34842,0.096538411529842,0.0292677419818794,0.0391736372453584,0.153903185814326,0.000975445909430449
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20652.Liking for dark chocolate,34842,-0.0125428714772147,0.0290401278619157,-0.0694615220865696,0.0443757791321402,0.665812046286063
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20653.Liking for diet fizzy drinks,34842,0.135888446830565,0.0300187434054681,0.0770517097558472,0.194725183905282,6.05538668294038e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20654.Liking for dried fruit,34842,0.0826323947500659,0.0288317560529249,0.0261221528863331,0.139142636613799,0.00416503203974277
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20655.Liking for eggs,34842,0.0125901708954192,0.0296912702715299,-0.0456047188367794,0.0707850606276178,0.671548261321638
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20656.Liking for exercising alone,34842,-0.051316789624199,0.0286193214106641,-0.107410659589101,0.00477708034070261,0.0729889161581306
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20657.Liking for exercising with others,34842,-0.0612645222602018,0.0286739117195484,-0.117465389230517,-0.00506365528988694,0.0326542989345769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20658.Liking for extra virgin olive oil,34842,-0.122887548817768,0.0291775106193746,-0.180075469631742,-0.0656996280037936,2.55571289168923e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20659.Liking for fatty foods,34842,0.0191468031084306,0.0287291924868292,-0.0371624141657546,0.0754560203826158,0.505133145870642
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20660.Liking for fresh tomatoes,34842,-0.0307147347347139,0.0316166239439595,-0.0926833176648745,0.0312538481954468,0.331334824716299
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20661.Liking for fried chicken,34842,0.0374272320822284,0.02858750566466,-0.0186042790205052,0.093458743184962,0.190490025942868
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20662.Liking for fried or battered fish,34842,0.0490108257295267,0.0288448679970354,-0.00752511554466264,0.105546767003716,0.089326971429998
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20663.Liking for fruit,34842,8.54372603870858e-05,0.0331569041616781,-0.064902094896502,0.0650729694172762,0.997944097749699
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20664.Liking for garlic,34842,-0.126298717023027,0.0290033935780537,-0.183145368436012,-0.0694520656100414,1.34577206604592e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20665.Liking for gherkins,34842,-0.112294591133752,0.0285591634337299,-0.168270551463863,-0.0563186308036414,8.47901445272055e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20666.Liking for globe artichoke,34842,-0.188031724412344,0.0288408042367542,-0.244559700716383,-0.131503748108306,7.37497353686447e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20667.Liking for goat's cheese,34842,-0.110213666005033,0.0287419330593074,-0.166547854801276,-0.0538794772087908,0.000126515004720949
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20668.Liking for going to a cafe,34842,0.0433654814857128,0.0290034454935932,-0.0134812716817298,0.100212234653155,0.134896880405285
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20669.Liking for going to the gym,34842,-0.0293165156110545,0.0284811633352086,-0.0851395957480632,0.0265065645259543,0.303348616230561
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20670.Liking for going to the pub,34842,-0.0688461411949853,0.0286492123134722,-0.124998597329391,-0.0126936850605799,0.0162753875320701
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20671.Liking for grapefruit,34842,-0.0543939419058833,0.0284177722356906,-0.110092775487837,0.00130489167607034,0.0556371639625767
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20672.Liking for green olives,34842,-0.116404232180202,0.02886027417251,-0.172970369558321,-0.059838094802082,5.53756827622288e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20673.Liking for haddock,34842,-0.0132847147078625,0.0294459725172326,-0.0709988208416383,0.0444293914259133,0.651886848112934
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20674.Liking for ham,34842,0.0555688699784408,0.0285560868765521,-0.000401060299601234,0.111538800256483,0.0516870528367537
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20675.Liking for hard cheese,34842,0.0353741462359831,0.0293507808619522,-0.0221533842534432,0.0929016767254093,0.228145880500293
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20676.Liking for herring,34842,-0.0481373041782246,0.0282879383102922,-0.103581663266397,0.00730705490994817,0.0888434236470732
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20677.Liking for honey,34842,0.0433746428413792,0.028519993497577,-0.0125245444138717,0.0992738300966301,0.128327845830223
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20678.Liking for horseradish or wasabi,34842,-0.104408191459898,0.0285167598020186,-0.160301040671855,-0.0485153422479416,0.000252192638350323
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20679.Liking for ice cream,34842,0.119100102434786,0.0288068805852823,0.0626386164876323,0.175561588381939,3.58631871891542e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20680.Liking for jam,34842,0.119134276737647,0.0285141661645926,0.0632465110550451,0.175022042420248,2.96395873983863e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20681.Liking for kiwi fruit,34842,-0.00253739537621785,0.0288263873094796,-0.0590371145027978,0.0539623237503621,0.929859809993765
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20682.Liking for lager,34842,-0.0756160754695906,0.028996057567247,-0.132448348301395,-0.0187838026377865,0.00912551900724261
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20683.Liking for lamb,34842,-0.0236426932647345,0.0290931045321173,-0.0806651781476845,0.0333797916182154,0.416433806542994
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20684.Liking for lemons,34842,-0.088850544220207,0.0286740039424385,-0.145051591947386,-0.0326494964930275,0.00194927601397167
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20685.Liking for lentils or beans,34842,-0.0730916034534062,0.02875070530478,-0.129442985850775,-0.0167402210560374,0.0110284045706311
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20686.Liking for liver,34842,0.0154220765049045,0.0287974035891145,-0.04102083452976,0.071864987539569,0.592290018858351
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20687.Liking for mackerel,34842,-0.0490800547682279,0.0285004774784924,-0.104940990626073,0.00678088108961719,0.0850851169210006
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20688.Liking for marzipan,34842,0.0532817669790479,0.0286405234108382,-0.00285365890619503,0.109417192864291,0.0628624587315384
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20689.Liking for mayonnaise,34842,-0.0320196765392523,0.0285926290689108,-0.0880612295143175,0.024021876435813,0.262800304244166
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20690.Liking for melon,34842,0.0430598888353326,0.0303510758396543,-0.0164282198103897,0.102547997481055,0.156008662155886
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20691.Liking for milk chocolate,34842,0.182167196519466,0.0290602510488947,0.125209104463632,0.2391252885753,3.78774000300106e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20692.Liking for mushrooms,34842,0.0330346398248429,0.029839161146773,-0.0254501160228322,0.0915193956725179,0.268280628556061
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20694.Liking for orange juice,34842,0.11891215164161,0.0285853354818405,0.0628848940972029,0.174939409186018,3.20950007977557e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20695.Liking for oranges,34842,-0.0216639123226576,0.029383408731044,-0.0792553934355038,0.0359275687901886,0.460966422707381
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20696.Liking for pasta,34842,-0.0154979198845496,0.0291750565114483,-0.0726810306469881,0.041685190877889,0.595288473749809
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20697.Liking for pears,34842,0.0127521652029222,0.0295363449851873,-0.0451390709680448,0.0706434013738893,0.665935823849684
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20698.Liking for pizza,34842,-0.0060684218655124,0.0286336168273131,-0.0621903108470461,0.0500534671160213,0.832163096507577
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20699.Liking for plain yogurt,34842,-0.0790550455163304,0.028916061665251,-0.135730526380222,-0.0223795646524385,0.00626857705084791
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20700.Liking for plums,34842,0.0321236315556217,0.0295272290149195,-0.0257497373136206,0.0899970004248639,0.276650172607819
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20701.Liking for pollock,34842,-0.0046741634438216,0.0284624712971353,-0.0604606071862068,0.0511122802985636,0.869559594224896
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20702.Liking for pork chop,34842,0.0217992891362797,0.0285506035385717,-0.0341598937993207,0.0777584720718802,0.44516375212335
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20703.Liking for porridge,34842,0.0219873246821738,0.0296464038194973,-0.0361196268040409,0.0800942761683886,0.458314782560825
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20704.Liking for potato crisps,34842,0.0368347797112175,0.0285975361386505,-0.0192163911205375,0.0928859505429724,0.19776063640338
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20705.Liking for potatoes,34842,0.0711376652975846,0.0292105435036732,0.0138850000303851,0.128390330564784,0.0148944348611752
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20706.Liking for prawns,34842,-0.0852598377285903,0.0291791161078963,-0.142450905300067,-0.0280687701571135,0.00348600434285117
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20707.Liking for raw carrots,34842,-0.0402258999771666,0.0293309701841071,-0.0977146015380164,0.0172628015836833,0.170264989521336
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20708.Liking for red meat,34842,-0.0461239979651452,0.0285530951837145,-0.102088064525226,0.0098400685949353,0.106259582710511
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20709.Liking for red wine,34842,-0.182670027599984,0.0289210121670728,-0.239355211447447,-0.125984843752521,2.7910328376133e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,34842,0.128256682445779,0.0301955842932931,0.069073337230924,0.187440027660633,2.18023749948288e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20711.Liking for roast chicken,34842,0.027073913833957,0.0305669538448172,-0.0328373157018848,0.0869851433697988,0.375786273352064
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20712.Liking for salad dressing,34842,-0.0259109073970265,0.0284180777527714,-0.0816103397924584,0.0297885249984053,0.361908075814487
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20713.Liking for salad leaves,34842,-0.0801030749793453,0.029620268122464,-0.138158800499375,-0.0220473494593158,0.00685531890190933
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20714.Liking for salami,34842,-0.123994368997438,0.0290950781980243,-0.181020722265566,-0.0669680157293103,2.046732032512e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20715.Liking for salmon,34842,-0.0379081186605513,0.0307438927957713,-0.0981661485402631,0.0223499112191605,0.217592777055373
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20716.Liking for salty foods,34842,-0.0041994840919624,0.0285612257662097,-0.0601794865937334,0.0517805184098086,0.883107684761366
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20717.Liking for salty pretzels,34842,-0.0609416647466794,0.028895811574793,-0.117577455433274,-0.00430587406008517,0.0349672774428678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20718.Liking for sardines,34842,-0.0558062552917215,0.0283921811761173,-0.111454930396911,-0.000157580186531614,0.0493772168673347
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20719.Liking for sausages (meat),34842,-0.00347452446417506,0.0287789791396634,-0.0598813235779153,0.0529322746495652,0.903906178290487
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20720.Liking for savoury biscuits,34842,0.0763990148233181,0.0286876004570713,0.0201713179274583,0.132626711719178,0.00775352995051208
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20721.Liking for shellfish (other than prawns),34842,-0.139954338729319,0.028356193705074,-0.195532478391264,-0.0843761990673737,8.1153789945339e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20722.Liking for skimmed milk,34842,0.043526343434953,0.0285548861087307,-0.0124412333381591,0.099493920208065,0.127463107724981
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20723.Liking for smoked fish,34842,-0.0572911344842835,0.0285976487926677,-0.113342526117912,-0.00123974285065487,0.0451655485502177
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20724.Liking for soft cheese,34842,0.0640594349619711,0.0286909809261164,0.007825112346783,0.120293757577159,0.0255874834716983
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20725.Liking for soy sauce,34842,-0.00467652241355256,0.02878974995618,-0.0611044323276653,0.0517513875005602,0.870964848273851
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20726.Liking for soya milk,34842,-0.0439941362081038,0.0290108757656121,-0.100855452708703,0.0128671802924958,0.12943088226195
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20727.Liking for spicy foods,34842,-0.153737808268037,0.0286219904694368,-0.209836909588133,-0.0976387069479409,7.98522331092154e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20728.Liking for spinach,34842,-0.101963254129451,0.0290730236013242,-0.158946380388046,-0.0449801278708556,0.00045486023644629
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20729.Liking for spirits,34842,-0.0795635922879138,0.0286751046057995,-0.135766797315281,-0.0233603872605468,0.00553586743867191
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20730.Liking for strawberries,34842,0.0491893099669541,0.0330556520172847,-0.0155997679869239,0.113978387920832,0.136761325879785
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20731.Liking for sweet coffee house drinks,34842,0.15783532849662,0.0298168454667182,0.0993943113818521,0.216276345611388,1.2244957046829e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20732.Liking for sweet foods,34842,0.22299561811033,0.0289321225337175,0.166288657944244,0.279702578276417,1.39990054485223e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20733.Liking for taking the stairs,34842,-0.0864602300258955,0.029405717239605,-0.144095435815521,-0.0288250242362697,0.00328668317401851
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20734.Liking for tea with sugar,34842,0.126489423980167,0.0376359792247116,0.0527229046997321,0.200255943260601,0.000779792020660214
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20735.Liking for tea without sugar,34842,-0.0189217409467188,0.0307266945129809,-0.0791460621921614,0.0413025802987237,0.538034819708346
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20736.Liking for tomato ketchup,34842,0.0657962961428654,0.0288170506664438,0.00931487683663554,0.122277715449095,0.0224362417581422
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20737.Liking for tinned tuna,34842,0.0207354860844225,0.0289250384490964,-0.0359575892758064,0.0774285614446515,0.47347057524534
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20738.Liking for turnip (white),34842,0.0450069956691307,0.0285249152724611,-0.0109018382648931,0.100915829603154,0.114638936942189
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20739.Liking for vegetables,34842,-0.0377516340454153,0.0331681616708809,-0.102761230920342,0.0272579628295113,0.255067871961329
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20740.Liking for vinegar,34842,0.00196075701273538,0.0286182410342442,-0.0541309954143832,0.058052509439854,0.945377605005928
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20741.Liking for watching television,34842,0.0790978648162912,0.0289768112326115,0.0223033148003728,0.13589241483221,0.00634997546994264
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20742.Liking for whisky,34842,-0.123380379546938,0.0309727487810521,-0.1840869671578,-0.0626737919360758,6.83673751977851e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20743.Liking for white bread,34842,0.0690513012182985,0.0286353151145512,0.012926083593778,0.125176518842819,0.0159085024680774
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20744.Liking for white rice,34842,5.10635321657962e-05,0.0288703413861925,-0.0565348055847716,0.0566369326491031,0.998588800839918
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20745.Liking for white wine,34842,-0.183423162814159,0.0286307021866101,-0.239539339099915,-0.127306986528403,1.55329188818535e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,34842,0.0711400201696532,0.0290018358992062,0.0142964218072091,0.127983618532097,0.0141853789286
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20747.Liking for whole milk,34842,0.0726635248853912,0.0286239716213746,0.016560540507497,0.128766509263285,0.0111456133611941
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20748.Liking for wholemeal bread,34842,0.0362483283631427,0.0304670515579134,-0.0234670926903676,0.095963749416653,0.234169892156028
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20749.Liking for working up a sweat,34842,-0.0832558938222141,0.0286868285463713,-0.139482077773102,-0.0270297098713263,0.00371290890530502
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X21001.Body mass index (BMI),51611,0.126682042075391,0.0148105237335394,0.0976534155576538,0.155710668593128,1.25582360994816e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X21002.Weight,51619,-0.0096006279097253,0.00916078288182571,-0.0275557623581037,0.0083545065386531,0.29464152044572
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X21021.Pulse wave Arterial Stiffness index,33423,0.0180126118299778,0.00651935801819047,0.0052346701143245,0.0307905535456311,0.00573995655654599
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34255,0.0486601640396889,0.0300839648771618,-0.0103044071195483,0.107624735198926,0.105807239990976
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34269,-0.0187990461364977,0.0312335350643937,-0.0800167748627094,0.0424186825897139,0.547263530378122
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34270,-0.038625326712769,0.0312784146577954,-0.099931019442048,0.02268036601651,0.216901896388096
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21040.Satisfaction with bowel habits,34224,0.0472525524621025,0.0291882638449733,-0.00995644467404515,0.10446154959825,0.105503499052465
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34204,0.064343125115576,0.0303221061125984,0.00491179713488309,0.123774453096269,0.0338639654058668
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21042.Greatest number of times bowels opened per day,34219,0.0199001884341971,0.0313039873406023,-0.0414556267533833,0.0812560036217776,0.524981797524979
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21043.Least number of times bowels opened per week,34129,-0.0350648493929996,0.031137465795489,-0.0960942823521581,0.0259645835661588,0.260138222116303
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21044.Average number of times bowels opened per day,34183,-0.0184038301002332,0.0354593986827768,-0.0879042515184758,0.0510965913180094,0.603764644488315
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34273,-0.0583979446255908,0.0318883118513364,-0.12089903585421,0.00410314660302854,0.067081944359582
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34267,-0.0190167212507328,0.0320670387678722,-0.0818681172357623,0.0438346747342966,0.553174630784352
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,34270,0.0518417697906348,0.0372351985813776,-0.0211392194288653,0.124822759010135,0.163869591369611
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34270,-0.0498181855165419,0.0329671597732322,-0.114433818672077,0.0147974476389932,0.130783490769412
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34268,-0.0778504327396691,0.0485168814413012,-0.172943520364619,0.0172426548852812,0.108612923846345
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34270,-0.0673003742697256,0.0361832292765334,-0.138219503651731,0.00361875511227983,0.0629171026033813
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34270,-0.00970565833495873,0.0922827496335262,-0.19057984761667,0.171168530946753,0.916240642978928
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34272,0.0527222896885349,0.0346592337207649,-0.0152098084041643,0.120654387781234,0.128251530966128
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34273,-0.0760018953491086,0.0359041620850747,-0.146374053035855,-0.0056297376623622,0.0343019880766903
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34009,0.0208721664381585,0.0321200998230253,-0.0420832292149711,0.0838275620912882,0.515826469545949
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34269,0.0271761573333136,0.0326364231326487,-0.0367912320066779,0.091143546673305,0.405037525514549
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34272,-0.115814816210849,0.0420649124980092,-0.198262044706947,-0.033367587714751,0.00591170165836867
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34272,-0.102017128211684,0.0317966106378452,-0.16433848506186,-0.0396957713615069,0.00133891422864156
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34270,-0.0387262400326394,0.03183605578057,-0.101124909362557,0.0236724292972778,0.223851523125431
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X21100.Water hardness (USGS classification),51479,-0.0273172721527494,0.0184509577060847,-0.0634811492566753,0.0088466049511765,0.138742423627733
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2139.Age first had sexual intercourse,47858,-0.0103392341831897,0.00467696938647995,-0.0195060941806904,-0.00117237418568899,0.0270683565838578
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2149.Lifetime number of sexual partners,46364,-0.0435341057050437,0.0210410760128112,-0.0847746146901536,-0.00229359671993387,0.0385572525525635
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22032.IPAQ activity group,45478,-0.100794381023206,0.0211000208315958,-0.142150421853134,-0.0594383401932781,1.7914732199381e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22033.Summed days activity,46151,-0.0246925899991352,0.00439165731311453,-0.0333002383328397,-0.0160849416654308,1.90403330655589e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22034.Summed minutes activity,45478,-0.015933064452253,0.00440506882311206,-0.0245669993455527,-0.00729912955895339,0.00029875311282428
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22037.MET minutes per week for walking,44452,-0.00978737226639083,0.00447008256888076,-0.0185487341013971,-0.00102601043138454,0.028569977402783
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22038.MET minutes per week for moderate activity,45478,-0.0172635584733255,0.00435176592631491,-0.0257930196889027,-0.00873409725774828,7.30170186659608e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22039.MET minutes per week for vigorous activity,45478,-0.114480814750388,0.021219175864191,-0.156070399444202,-0.0728912300565735,6.92029119657688e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22040.Summed MET minutes per week for all activity,44452,-0.0198407679024307,0.0045549203595002,-0.0287684118070511,-0.0109131239978103,1.33181855007495e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X2217.Age started wearing glasses or contact lenses,47872,-0.00625768939405906,0.00421966739995208,-0.0145282374979651,0.00201285870984702,0.138092737658459
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X22501.Year ended full time education,31224,-0.0421204019947921,0.0194707147428671,-0.0802830028908116,-0.0039578010987726,0.0305553343269429
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X22506.Tobacco smoking,31179,-0.0864709337294758,0.0794365403517231,-0.242166552818853,0.0692246853599014,0.27638978599882
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,49860,0.0467172842691998,0.0433740653135611,-0.0382958837453799,0.131730452283779,0.28145530995309
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23098.Weight,51201,-0.00859830279204103,0.00923732075765032,-0.0267034514770357,0.00950684589295359,0.351953969078653
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23099.Body fat percentage,51202,0.0489833235729421,0.00947860695949838,0.0304052539323253,0.0675613932135589,2.38595721072362e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23100.Whole body fat mass,51193,0.0370795543987364,0.00909059498738706,0.0192619882234578,0.0548971205740151,4.53818985049871e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23101.Whole body fat-free mass,51201,-0.034343351096323,0.0075956644813027,-0.0492308534796763,-0.0194558487129697,6.16833961447887e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23102.Whole body water mass,51201,-0.0348127294504617,0.00762294324891185,-0.049753698218329,-0.0198717606825945,4.97348166083702e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23104.Body mass index (BMI),51201,0.128229682858671,0.0150119324662586,0.098806295224804,0.157653070492538,1.39003140749873e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23105.Basal metabolic rate,51199,-0.0330673470519529,0.00828363425981003,-0.0493032702011805,-0.0168314239027252,6.57239682684087e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23106.Impedance of whole body,51195,0.0219394878540341,0.00621211710527949,0.00976373832768625,0.0341152373803819,0.000413553628141004
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23107.Impedance of leg (right),51198,0.0244105584124346,0.00507395074350245,0.0144656149551698,0.0343555018696994,1.51027259694504e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23108.Impedance of leg (left),51197,0.0202496190236761,0.00502533689044938,0.0103999587183953,0.0300992793289569,5.60489964386926e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23109.Impedance of arm (right),51188,0.00940078076607469,0.00622702648610507,-0.00280419114669125,0.0216057526788406,0.131138413907858
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23110.Impedance of arm (left),51196,0.00590014015513156,0.00624757469086819,-0.00634510623897008,0.0181453865492332,0.344979485961145
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23111.Leg fat percentage (right),51197,0.0584468695855788,0.0149353756006723,0.029173533408261,0.0877202057628966,9.12619125655007e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23112.Leg fat mass (right),51196,0.0723398243014372,0.017170410133844,0.038685820439103,0.105993828163771,2.5276844051914e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23113.Leg fat-free mass (right),51196,-0.0409053920789587,0.00771526211540907,-0.0560273058251605,-0.0257834783327569,1.15525290963481e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23114.Leg predicted mass (right),51195,-0.039949943080373,0.00774397733595661,-0.0551281386588479,-0.024771747501898,2.50256286457895e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23115.Leg fat percentage (left),51192,0.0476509555569825,0.0154156324298272,0.0174363159945212,0.0778655951194438,0.00199634718608127
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23116.Leg fat mass (left),51192,0.0632145570265382,0.0172325036189616,0.0294388499333734,0.0969902641197029,0.000244610987026859
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23117.Leg fat-free mass (left),51190,-0.0374951924122649,0.00791811951881138,-0.0530147066691352,-0.0219756781553945,2.19780790757691e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23118.Leg predicted mass (left),51189,-0.0370774561820953,0.00794751779468651,-0.0526545910596808,-0.0215003213045097,3.0967690740475e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23119.Arm fat percentage (right),51189,0.0621243560502313,0.010563528623599,0.0414198399479772,0.0828288721524854,4.12583884914974e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23120.Arm fat mass (right),51185,0.0568151865290756,0.00949611350331298,0.0382028040625821,0.075427568995569,2.21858629037859e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23121.Arm fat-free mass (right),51187,-0.0242983024719952,0.00739227416173103,-0.038787159828988,-0.00980944511500237,0.00101396351756752
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23122.Arm predicted mass (right),51186,-0.0225122786239512,0.0073889344160167,-0.036994590079344,-0.0080299671685585,0.00231551081773338
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23123.Arm fat percentage (left),51183,0.0654486805591455,0.01186047703332,0.0422021455738383,0.0886952155444527,3.45631874302161e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23124.Arm fat mass (left),51182,0.0545254168367593,0.00974214197760437,0.0354308185606547,0.0736200151128639,2.20405421920301e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23125.Arm fat-free mass (left),51182,-0.0211613034276953,0.00797302942103951,-0.0367884410929328,-0.00553416576245789,0.00795647782023725
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23126.Arm predicted mass (left),51180,-0.0209214308569381,0.00798071779438354,-0.0365636377339299,-0.0052792239799464,0.0087594015024406
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23127.Trunk fat percentage,51178,0.0276343042231044,0.00599472250543123,0.0158846481124592,0.0393839603337496,4.04974330296909e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23128.Trunk fat mass,51175,0.0220169724291668,0.00690809383568686,0.00847710851122056,0.035556836347113,0.00143859003084353
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23129.Trunk fat-free mass,51169,-0.030208294463524,0.00709184355307901,-0.0441083078275589,-0.0163082810994891,2.05508890567537e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23130.Trunk predicted mass,51166,-0.0304596356228864,0.00710305914030533,-0.0443816315378849,-0.016537639707888,1.80724490403016e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23400.Total Cholesterol,40042,-0.0523104860152125,0.00513133867527449,-0.0623679098187505,-0.0422530622116746,2.50607173615396e-24
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40042,0.0186833152012381,0.00497993655199037,0.00892263955933693,0.0284439908431392,0.000176263541964823
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40042,0.0381053384796739,0.00496335065517045,0.0283771711955398,0.0478335057638079,1.72027219244604e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23403.VLDL Cholesterol,40042,0.0994619531098789,0.00481136866909444,0.0900316705184538,0.108892235701304,1.10686589443907e-93
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23404.Clinical LDL Cholesterol,40042,-0.00193641187235177,0.00498690310944993,-0.0117107419668736,0.00783791822217008,0.697799725881289
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23405.LDL Cholesterol,40042,-0.000359883333828269,0.00498587559973093,-0.0101321995093009,0.00941243284164435,0.942459135076731
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23406.HDL Cholesterol,40042,-0.238700088211072,0.00541974177827117,-0.249322782096484,-0.228077394325661,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23407.Total Triglycerides,40042,0.141932217844565,0.00515117308666233,0.131835918594707,0.152028517094423,3.19203467428942e-163
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23408.Triglycerides in VLDL,40042,0.15439298174392,0.00513167969188066,0.144334889547834,0.164451073940006,2.35544866183877e-193
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23409.Triglycerides in LDL,40042,0.0798040401446269,0.00521314954315872,0.0695862670400358,0.090021813249218,1.62347215792668e-52
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23410.Triglycerides in HDL,40042,0.0664447691256572,0.00493827344345011,0.0567657531764949,0.0761237850748194,4.87131515779766e-41
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40042,-0.069185212557029,0.00521265592757148,-0.0794020181750691,-0.0589684069389889,5.50471989293462e-40
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23412.Phospholipids in VLDL,40042,0.128209633151519,0.00491477182750488,0.118576680369609,0.137842585933428,7.20291471498067e-147
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23413.Phospholipids in LDL,40042,0.0111473532072374,0.00494788744951657,0.0014494938061849,0.0208452126082899,0.0242760150082168
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23414.Phospholipids in HDL,40042,-0.192347391242151,0.00535479387062254,-0.202842787228571,-0.181851995255731,1.48863243636906e-271
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23415.Total Esterified Cholesterol,40042,-0.0651196116215959,0.00513889557293018,-0.0751918469445391,-0.0550473762986528,1.2826182357888e-36
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40042,0.0861861897140219,0.00479925755759668,0.0767796449011324,0.0955927345269114,2.166107097678e-71
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40042,0.00992430431984046,0.00497532588842722,0.000172665578523103,0.0196759430611578,0.0460925122406741
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40042,-0.241514312412409,0.00537279082884662,-0.252044982436949,-0.23098364238787,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23419.Total Free Cholesterol,40042,-0.019880513734295,0.0051016811110093,-0.0298798087118732,-0.00988121875671679,9.78571500551087e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23420.Free Cholesterol in VLDL,40042,0.116915942452618,0.00487351396254589,0.107363855086028,0.126468029819208,6.41524781121749e-125
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23421.Free Cholesterol in LDL,40042,-0.0282287643964383,0.00502226653256589,-0.0380724068002674,-0.0183851219926092,1.93418071105957e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23422.Free Cholesterol in HDL,40042,-0.214260003739728,0.0055025856543799,-0.225045071622313,-0.203474935857143,1.66880539733507e-308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40042,-0.00789571115152607,0.00512400704640323,-0.0179387649624764,0.00214734265942427,0.123355308234398
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23424.Total Lipids in VLDL,40042,0.138731924574487,0.00500028154028461,0.12893137275553,0.148532476393445,2.04091440393157e-165
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23425.Total Lipids in LDL,40042,0.00728253606784645,0.00497492223519532,-0.00246831151313637,0.0170333836488293,0.143255310711047
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23426.Total Lipids in HDL,40042,-0.209249049200672,0.0053849319888476,-0.219803515898813,-0.19869458250253,1.66880545251139e-308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40042,-0.155627257943121,0.00512911225363108,-0.165680317960238,-0.145574197926004,1.58106696546145e-196
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23428.Concentration of VLDL Particles,40042,0.10682235736274,0.00487310164283222,0.0972710781427889,0.116373636582691,6.28769201397456e-105
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23429.Concentration of LDL Particles,40042,0.0470745719916181,0.00492183439847739,0.0374277765706024,0.0567213674126338,1.2932467395488e-21
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23430.Concentration of HDL Particles,40042,-0.171324639226916,0.00510952884530393,-0.181339315763712,-0.16130996269012,4.53390295518096e-238
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40042,0.173314998584392,0.00539258087385534,0.162745540071635,0.183884457097148,1.67651931345858e-219
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23432.Average Diameter for LDL Particles,40042,-0.0564194529211855,0.00507098317405859,-0.0663585799423403,-0.0464803259000306,1.20260503505561e-28
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23433.Average Diameter for HDL Particles,40042,-0.204534788957908,0.00579991380751206,-0.215902620020632,-0.193166957895184,3.55253811554513e-262
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23434.Phosphoglycerides,40028,-0.0855128195616874,0.00522341676798454,-0.0957507164269371,-0.0752749226964377,9.70663900818274e-60
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40028,0.210890259881427,0.00532866658083223,0.200446073382996,0.221334446379858,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23436.Total Cholines,40028,-0.0966344403225426,0.00522404165175385,-0.10687356195998,-0.0863953186851051,1.38006670061125e-75
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23437.Phosphatidylcholines,40028,-0.100194336579176,0.00522278206071942,-0.110430989418186,-0.0899576837401656,4.32351973376741e-81
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23438.Sphingomyelins,40027,-0.0968378011783688,0.00525680603420437,-0.107141141005409,-0.0865344613513282,5.52994706117411e-75
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23439.Apolipoprotein B,40042,0.0492053949172283,0.00491802948243195,0.0395660571316617,0.0588447327027949,1.70396241426182e-23
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23440.Apolipoprotein A1,40042,-0.194224287682274,0.00524191145726673,-0.204498434138517,-0.183950141226032,4.36882927720847e-288
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40042,0.136540938830789,0.00486236778108342,0.127010697979865,0.146071179681712,2.64037624469661e-169
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23442.Total Fatty Acids,40028,0.0352846327602302,0.00527047437223054,0.0249545029906583,0.045614762529802,2.23387714428238e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23443.Degree of Unsaturation,40028,-0.134064079643871,0.00543784933134036,-0.144722264333298,-0.123405894954443,1.10323586240473e-131
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23444.Omega-3 Fatty Acids,40028,-0.0222857316548164,0.00517473947787594,-0.0324282210314532,-0.0121432422781795,1.66768570835169e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23445.Omega-6 Fatty Acids,40028,-0.0208286170014435,0.00510117785571281,-0.0308269255986406,-0.0108303084042464,4.46609266788465e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40028,-0.0238164278995486,0.00514386981660662,-0.0338984127400976,-0.0137344430589997,3.68512056494067e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40028,0.0944611425939461,0.00536493275370088,0.0839458743966924,0.1049764107912,1.0049685107518e-68
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23448.Saturated Fatty Acids,40028,0.036855184929064,0.00538211275221527,0.0263062439347221,0.0474041259234059,7.78436397982734e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23449.Linoleic Acid,40028,-0.00846715980853645,0.00505311043494945,-0.0183712562610374,0.00143693664396446,0.0938301250898616
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23450.Docosahexaenoic Acid,40028,-0.0920779997245815,0.00539175469666788,-0.102645838930051,-0.0815101605191124,8.47583200818082e-65
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40028,-0.0473572993772376,0.00516235571627767,-0.0574755165811418,-0.0372390821733334,5.13797962904229e-20
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40028,-0.125118399311315,0.00568647964845094,-0.136263899422279,-0.113972899200351,1.09637795444033e-105
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40028,-0.150424135924309,0.00567555970251617,-0.16154823294124,-0.139300038907377,1.95546541020356e-151
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40028,0.187871062624906,0.00551260662810306,0.177066353633824,0.198675771615988,1.3692086238644e-245
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40028,0.0211722070790937,0.00538450469027187,0.0106185778861608,0.0317258362720265,8.45848909187616e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40028,-0.0813397409090319,0.0055179101802502,-0.0921548448623223,-0.0705246369557415,7.49589256737787e-49
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40028,-0.119356209237698,0.00543237079523966,-0.130003655996368,-0.108708762479029,2.14901728601271e-105
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40028,-0.181825921156794,0.00558988895553099,-0.192782103509635,-0.170869738803953,1.31347705679823e-224
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40026,0.0159351460548413,0.00515247227755974,0.00583630039082426,0.0260339917188584,0.00198682880717973
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23460.Alanine,40035,0.0177924683589521,0.00492526967843788,0.00813893978921387,0.0274459969286904,0.000304228965061278
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23461.Glutamine,39992,-0.058538218317143,0.00495043110294467,-0.0682410632789145,-0.0488353733553714,3.98691687436526e-32
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23462.Glycine,40021,-0.00346316017967708,0.00475248940966458,-0.0127780394226196,0.00585171906326549,0.466193431020078
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23463.Histidine,40022,-0.00224507789584212,0.00485573610042888,-0.0117623206526827,0.00727216486099848,0.643832629531308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40032,0.0528747316449104,0.00493758672777833,0.0431970616584648,0.0625524016313559,1.1482221266509e-26
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23465.Isoleucine,40038,0.0587526754363024,0.00484437543141067,0.0492576995907375,0.0682476512818673,1.06442553649741e-33
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23466.Leucine,40039,0.0469527410500432,0.00494311629217533,0.0372642331173796,0.0566412489827069,2.42948655145795e-21
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23467.Valine,40032,0.0496070491488327,0.00498043233889461,0.0398454017645992,0.0593686965330661,2.66699590341242e-23
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23468.Phenylalanine,40039,0.0349561415600039,0.00482558051150836,0.0254980037574475,0.0444142793625602,4.56280421691135e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23469.Tyrosine,40023,0.0144977518390024,0.00486834128084467,0.00495580292854685,0.0240397007494579,0.00290615616300534
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23470.Glucose,40009,0.0152132623781697,0.00513798885050338,0.00514280423118307,0.0252837205251563,0.00307167436879737
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23471.Lactate,40009,-0.00208796300225906,0.00483160757661876,-0.0115579138524318,0.00738198784791371,0.665640824654974
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23472.Pyruvate,39994,-0.0412112137642424,0.00497709877254668,-0.0509663273584339,-0.0314561001700509,1.32923608154813e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23473.Citrate,40040,0.00613784995879531,0.00495759612493526,-0.0035790384460778,0.0158547383636684,0.215708832869163
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23474.3-Hydroxybutyrate,39849,-0.0104221109444772,0.00465944355099933,-0.0195546203044358,-0.00128960158451847,0.0253155304918001
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23475.Acetate,40028,-0.0211241873458285,0.00501926474797409,-0.0309619462518577,-0.0112864284397993,2.58372970581716e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23476.Acetoacetate,40041,0.0160625267540859,0.00483350079540967,0.006588865195083,0.0255361883130889,0.000892067855405363
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23477.Acetone,40041,-0.0550948649713802,0.00483101208443843,-0.0645636486568795,-0.0456260812858809,5.22677832358655e-30
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23478.Creatinine,39565,0.0532397898599075,0.00568555518599944,0.0420961016953486,0.0643834780244665,8.73585060397255e-21
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23479.Albumin,40041,-0.0794515316979199,0.00498206190424359,-0.0892163730302374,-0.0696866903656025,8.33840121218924e-57
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23480.Glycoprotein Acetyls,40042,0.1612471959293,0.00518781953786212,0.15107906963509,0.17141532222351,7.6377578409562e-206
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40042,0.165274409896445,0.00515819356446535,0.155164350510093,0.175384469282797,3.24982448038225e-218
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40042,0.162424589209772,0.0051671806595591,0.152296915117036,0.172552263302508,2.40795253255817e-210
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40042,0.165073943773685,0.00507345908107316,0.155129963974782,0.175017923572588,9.79978718231973e-225
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40042,0.160592291067528,0.00507822576205889,0.150638968573892,0.170545613561163,8.62883120012648e-213
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40042,0.158372317308637,0.00505242382093041,0.148469566619613,0.16827506799766,3.25206818277797e-209
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40042,0.156078284886226,0.00511110784340434,0.146060513513153,0.166096056259298,5.7744969971861e-199
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40042,0.157452068492083,0.00521491722835742,0.147230830724503,0.167673306259664,1.13449237008333e-194
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40042,0.168830886128642,0.00505016547199177,0.158932561803538,0.178729210453746,1.02212547358287e-236
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40042,0.169983464646985,0.00506010132328069,0.160065666053354,0.179901263240615,6.40337296705861e-239
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40042,0.168913085079569,0.00501363007930592,0.15908637012413,0.178739800035009,2.96468804990398e-240
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40042,0.1534409549082,0.00489677767846935,0.143843270658401,0.163038639158,4.46271240143973e-209
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40042,0.140906037170364,0.00481658406410022,0.131465532404727,0.150346541936,3.38882158963602e-183
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40042,0.163196897793851,0.00498845288631185,0.15341953013668,0.172974265451022,4.22527614741674e-227
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40042,0.171301337407651,0.00512118280597902,0.161263819107932,0.18133885570737,5.68192095244373e-237
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40042,0.158118969086766,0.00502389886846939,0.148272127304566,0.167965810868966,7.48459441998677e-211
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23496.Total Lipids in Large VLDL,40042,0.155900709070036,0.00501850415112096,0.146064440933839,0.165736977206233,1.24595486413771e-205
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23497.Phospholipids in Large VLDL,40042,0.162732884081655,0.00497549736613273,0.152980909244034,0.172484858919275,5.4112291249016e-227
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23498.Cholesterol in Large VLDL,40042,0.146210493084145,0.00485849120060775,0.136687850330954,0.155733135837336,1.89935497246706e-193
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40042,0.132414223457067,0.00476262873537066,0.123079471135741,0.141748975778394,4.39614462761023e-166
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40042,0.158627825119074,0.004965404433292,0.148895632429822,0.168360017808327,5.56753262847181e-217
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23501.Triglycerides in Large VLDL,40042,0.150976003210056,0.00511104387896492,0.140958357207285,0.160993649212828,1.20441850329872e-186
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40042,0.0912337829535839,0.00486365546382136,0.081701018244494,0.100766547662674,1.18485776615252e-77
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40042,0.103252385989365,0.0049008543754472,0.0936467114134882,0.112858060565241,3.50526899937484e-97
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40042,0.086734422330374,0.00485679176419747,0.077215110472547,0.0962537341882011,1.25606431952166e-70
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40042,0.0447478558278233,0.00492994594699334,0.0350851617717164,0.0544105498839303,1.25015455300841e-19
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40042,0.0198058754816048,0.0050233350048334,0.00996013887213132,0.0296516120910782,8.0896478600389e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40042,0.0740087865466067,0.00485722657811396,0.0644886224535033,0.0835289506397101,4.77411618068106e-52
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40042,0.132949369018215,0.00504397187979902,0.123063184133809,0.142835553902621,7.80055596016663e-150
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40042,0.120242964270341,0.00485926862894473,0.110718797757609,0.129767130783073,1.25177078045908e-132
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23510.Total Lipids in Small VLDL,40042,0.114600655074738,0.00483976511253159,0.105114715454176,0.1240865946953,8.31185394063777e-122
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23511.Phospholipids in Small VLDL,40042,0.0915829913242159,0.00481447470276849,0.0821466209067896,0.101019361741642,8.89527923242353e-80
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23512.Cholesterol in Small VLDL,40042,0.0912586816972622,0.00475936931521769,0.0819303178394356,0.100587045555089,5.16439262097019e-81
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40042,0.102344703284772,0.00471596232998882,0.0931014171179938,0.11158798945155,6.54966352473597e-103
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40042,0.069672460795388,0.0048477024111109,0.0601709640696106,0.0791739575211653,1.53241750538608e-46
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23515.Triglycerides in Small VLDL,40042,0.128379047258768,0.00500177060590234,0.1185755768712,0.138182517646337,2.44589124443561e-142
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40042,0.0607763280106184,0.00496020788197481,0.0510543205619478,0.070498335459289,2.33594368773152e-34
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40042,0.0604341238575393,0.00495744720381377,0.0507175273380643,0.0701507203770143,4.98496435821416e-34
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40042,0.0738060704646091,0.00493716359734752,0.064129229813808,0.0834829111154103,3.51563733958327e-50
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40042,0.0262470849078755,0.00506771004464476,0.0163143732203717,0.0361797965953792,2.25518132032409e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40042,0.0127108106499252,0.00510868303683508,0.0026977918977284,0.0227238294021219,0.012853856602698
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40042,0.0565441424431665,0.00497557287370767,0.0467920196106994,0.0662962652756335,8.24483659407143e-30
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40042,0.106155293816857,0.00499625161608214,0.0963626406493359,0.115947946984378,8.80220244399194e-99
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23523.Concentration of IDL Particles,40042,0.016993034038787,0.0049993457509281,0.00719431636696789,0.026791751710606,0.00067789270267092
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23524.Total Lipids in IDL,40042,-0.0273396523535478,0.00513146989131123,-0.0373973333405178,-0.0172819713665778,1.00768727406578e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23525.Phospholipids in IDL,40042,-0.0168880862409078,0.00515214200517135,-0.0269862845710437,-0.00678988791077199,0.00104819951198837
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23526.Cholesterol in IDL,40042,-0.0412088127430577,0.00513148959404778,-0.0512665323473913,-0.031151093138724,1.03901506973587e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40042,-0.042065801861557,0.00511797845741809,-0.0520970396380965,-0.0320345640850176,2.2080684916739e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23528.Free Cholesterol in IDL,40042,-0.0379678465510453,0.00516441166015353,-0.0480900934049462,-0.0278455996971444,2.05227015009346e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23529.Triglycerides in IDL,40042,0.0780002779387414,0.0051002721927092,0.0680037444410313,0.0879968114364514,2.03314440644343e-52
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23530.Concentration of Large LDL Particles,40042,0.0386159033938958,0.00494969935507998,0.028914492657939,0.0483173141298525,6.49499525152578e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23531.Total Lipids in Large LDL,40042,-0.0123816151274944,0.00501340608268687,-0.0222078910495607,-0.00255533920542818,0.0135332232007057
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23532.Phospholipids in Large LDL,40042,-0.00597056427740006,0.0049901157284006,-0.0157511911050652,0.00381006255026513,0.23152822780655
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23533.Cholesterol in Large LDL,40042,-0.0205537867602858,0.00502742200461387,-0.030407533889329,-0.0107000396312426,4.36658542335376e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40042,-0.0124712221672155,0.00500879153538697,-0.0222884535765739,-0.00265399075785702,0.0127894459736773
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40042,-0.0423616596137653,0.00507046822553453,-0.052299777335813,-0.0324235418917177,7.1139821934341e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23536.Triglycerides in Large LDL,40042,0.0670187726904075,0.00518248553790219,0.0568611010361192,0.0771764443446958,4.67379584810031e-38
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40042,0.0551600418580274,0.00490483858739043,0.0455465582267422,0.0647735254893127,3.13859170207537e-29
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23538.Total Lipids in Medium LDL,40042,0.0382197528215473,0.00493615419109005,0.0285448906070108,0.0478946150360838,1.03185827576058e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23539.Phospholipids in Medium LDL,40042,0.035087579334669,0.00490327735690732,0.0254771557151306,0.0446980029542073,8.68007463502465e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23540.Cholesterol in Medium LDL,40042,0.0342398527492499,0.00493810073030687,0.0245611753178484,0.0439185301806514,4.25740650035189e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40042,0.0485268071225077,0.00494705683702299,0.0388305757219427,0.0582230385230728,1.19490762142455e-22
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40042,-0.00533546973306785,0.0049490770752957,-0.0150356608006474,0.00436472133451172,0.281017556748055
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23543.Triglycerides in Medium LDL,40042,0.0875442792114447,0.00524032943989642,0.0772732335092478,0.0978153249136417,4.11748739672284e-62
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23544.Concentration of Small LDL Particles,40042,0.0616101310217897,0.00488242285078763,0.052040582234246,0.0711796798093335,2.50487812664668e-36
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23545.Total Lipids in Small LDL,40042,0.0420974527886435,0.00494102765099602,0.0324130385926913,0.0517818669845957,1.7400829844319e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23546.Phospholipids in Small LDL,40042,0.0306669609802579,0.00492094644337727,0.0210219059512384,0.0403120160092773,4.72585163006377e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23547.Cholesterol in Small LDL,40042,0.0361855455057375,0.00493169539491029,0.0265194225317133,0.0458516684797617,2.28605724490356e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40042,0.0495897358024251,0.00495489073774809,0.0398781499564388,0.0593013216484114,1.6511415860696e-23
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40042,-0.000724275874914349,0.00491686154352304,-0.0103613245002195,0.0089127727503908,0.882893578565172
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23550.Triglycerides in Small LDL,40042,0.121279549220222,0.00524262500613035,0.111004004208206,0.131555094232237,1.93786737880399e-116
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40042,-0.162443357192921,0.00556638218660487,-0.173353466278667,-0.151533248107176,2.45613976992037e-182
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40042,-0.164750815915513,0.00560388902467511,-0.175734438403877,-0.15376719342715,5.99136480721599e-185
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40042,-0.162129978209132,0.00561474541251989,-0.173134879217671,-0.151125077200593,1.17151957062364e-178
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40042,-0.172325939707404,0.00554921045435518,-0.18320239219794,-0.161449487216868,1.72133668193183e-205
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40042,-0.187962664172189,0.00561211653709575,-0.198962412584897,-0.176962915759482,1.49446173222901e-237
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40042,-0.112268911769263,0.00525228366590815,-0.122563387754443,-0.101974435784083,6.14461388786795e-100
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40042,0.0238263581339173,0.00514683222099357,0.0137385669807699,0.0339141492870647,3.69818917297891e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23558.Concentration of Large HDL Particles,40042,-0.237947046210682,0.00575242944572519,-0.249221807924303,-0.22667228449706,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23559.Total Lipids in Large HDL,40042,-0.234406958455749,0.00572945802146012,-0.245636696177811,-0.223177220733687,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23560.Phospholipids in Large HDL,40042,-0.227443481920154,0.00566560555815345,-0.238548068814135,-0.216338895026173,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23561.Cholesterol in Large HDL,40042,-0.239703058483576,0.00571484619884011,-0.250904157033302,-0.228501959933849,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40042,-0.243132460029531,0.00568868728268124,-0.254282287103586,-0.231982632955475,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40042,-0.222202661889406,0.00574852765304785,-0.23346977608938,-0.210935547689432,1.66888638866362e-308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23564.Triglycerides in Large HDL,40042,-0.0314274109297507,0.00508306687457943,-0.0413902220039264,-0.021464599855575,6.45573200818161e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40042,-0.190494400547308,0.00520573092197972,-0.200697633154389,-0.180291167940228,2.50010376762918e-281
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23566.Total Lipids in Medium HDL,40042,-0.174500436661714,0.00519077949980773,-0.184674364481338,-0.164326508842091,2.97070251552714e-239
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23567.Phospholipids in Medium HDL,40042,-0.155214010627286,0.00519416415959756,-0.165394572380097,-0.145033448874475,7.67026717290755e-191
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23568.Cholesterol in Medium HDL,40042,-0.207169761454665,0.00518492279925659,-0.217332210141207,-0.197007312768122,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40042,-0.20786475712015,0.0051552831498824,-0.21796911209392,-0.197760402146381,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40042,-0.196808201268499,0.00527873639756887,-0.207154524607734,-0.186461877929264,1.63093689453017e-291
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23571.Triglycerides in Medium HDL,40042,0.065952254588161,0.00489426060334807,0.0563595038055988,0.0755450053707232,3.70911246304797e-41
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23572.Concentration of Small HDL Particles,40042,-0.0510449035164889,0.00486421884579274,-0.0605787724542427,-0.0415110345787351,1.12147966787715e-25
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23573.Total Lipids in Small HDL,40042,-0.0404018218102979,0.00492217648255329,-0.0500492877161024,-0.0307543559044935,2.42107572420159e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23574.Phospholipids in Small HDL,40042,-0.0464652880264957,0.00497091712436785,-0.0562082855902567,-0.0367222904627347,1.01736929331389e-20
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23575.Cholesterol in Small HDL,40042,-0.0687637426143557,0.00486029208976721,-0.0782899151102994,-0.0592375701184119,3.65297472874483e-45
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40042,-0.0635083086835631,0.00480997972085363,-0.0729358689364362,-0.05408074843069,1.36709910806346e-39
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40042,-0.0762786811737302,0.00503049418965472,-0.0861384497854534,-0.0664189125620069,1.44408685555327e-51
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23578.Triglycerides in Small HDL,40042,0.137439113646837,0.00496495853534482,0.127707794917561,0.147170432376113,1.07990729875365e-164
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39187,0.0416395207604257,0.00460893649841265,0.0326060052235369,0.0506730362973145,1.84869692822128e-19
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39187,-0.0368817488610501,0.00484071029079447,-0.0463695410310073,-0.027393956691093,2.71015287313254e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39187,-0.0156361989238492,0.00473231799400717,-0.0249115421921033,-0.00636085565559517,0.000954984830108801
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39187,-0.0637342527137253,0.00491402552360923,-0.0733657427399994,-0.0541027626874512,2.93697169049494e-38
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39187,0.0115558753245048,0.00469840327737786,0.00234700490084419,0.0207647457481654,0.0139232146670752
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39810,0.0786837190852625,0.00450865792799322,0.0698467495463958,0.0875206886241292,1.4977458620883e-67
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39810,-0.10318715808675,0.00510303879382622,-0.113189114122649,-0.0931852020508506,9.44965003060894e-90
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39810,-0.108681425376368,0.00510895163336392,-0.118694970577761,-0.0986678801749748,5.41729491040729e-99
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39810,-0.0557784722820639,0.00488157285714314,-0.0653463550820645,-0.0462105894820633,4.08747146354574e-30
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39810,0.064410128163508,0.00493123746453836,0.0547449027330129,0.0740753535940032,8.7755508347818e-39
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40037,0.142602354743086,0.004726168800573,0.133339063893963,0.151865645592209,1.9988685607012e-194
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40037,-0.0148805214244739,0.00479719334534698,-0.024283020381354,-0.00547802246759384,0.00192611800116079
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40037,-0.0540267062397145,0.00502013158243928,-0.0638661641412954,-0.0441872483381335,6.46826834003433e-27
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40037,0.0677520064934875,0.00458188475073524,0.0587715123820465,0.0767325006049286,3.82950226556794e-49
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40037,-0.054842845324991,0.00451090790415234,-0.0636842248171296,-0.0460014658328524,7.4190775115713e-34
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40042,-0.0507026848614546,0.00505708966272743,-0.0606145806004004,-0.0407907891225089,1.38039325724613e-23
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40042,-0.105637688832607,0.00523414927284454,-0.115896621407382,-0.0953787562578312,1.93571425737069e-89
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40042,-0.114777245073259,0.00526129864170849,-0.125089390411008,-0.10446509973551,5.91585262184283e-104
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40042,-0.0762166517091453,0.00514873632405176,-0.0863081749042867,-0.0661251285140038,3.02593662730454e-49
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40042,0.0948722028067548,0.00520937071691989,0.0846618362015918,0.105082569411918,2.39241562550509e-73
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40042,-0.0926341731620174,0.00510499818757338,-0.102639969609661,-0.0826283767143735,7.78133816777149e-73
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40042,-0.0349992870099729,0.00504524138906103,-0.0448879601325325,-0.0251106138874133,4.16009627167363e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40042,0.0154359261950521,0.00491302080444146,0.00580640541834683,0.0250654469717573,0.00168203863978249
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40042,-0.100390115836011,0.00511296741867156,-0.110411531976607,-0.0903686996954147,8.29653871249343e-85
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40042,0.0533932822826759,0.00507523465679008,0.0434458223553673,0.0633407422099845,8.49383588179223e-26
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40042,0.130257332449023,0.0050770811386123,0.120306253417343,0.140208411480704,3.19001889616557e-142
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40042,-0.10957791769036,0.0053084256410871,-0.11998243194689,-0.0991734034338289,2.02680592652729e-93
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40042,-0.120608449211199,0.00532756664235864,-0.131050479830222,-0.110166418592177,1.13357858006862e-111
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40042,-0.00526132886078954,0.00525520567825658,-0.0155615319901724,0.00503887426859336,0.316762503369366
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40042,0.0900430898423843,0.00532430659716141,0.079607448911948,0.100478730772821,1.36033299193536e-63
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40042,0.0660156621687512,0.00480643989131864,0.0565950399817666,0.0754362843557357,1.11278833283282e-42
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40042,-0.104984135831769,0.00504299993907068,-0.114868415712348,-0.095099855951191,5.82564631771351e-95
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40042,-0.0958729597237937,0.00503459973166986,-0.105740775197867,-0.0860051442497208,6.08127316027396e-80
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40042,-0.0555249857318319,0.00523670588285326,-0.0657889292622243,-0.0452610422014395,3.54192394386345e-26
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40042,0.107652094271098,0.00521363042571501,0.0974333786366965,0.117870809905499,1.79828080382579e-93
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40042,0.0466594608750484,0.00479738884364938,0.0372565787414957,0.0560623430086012,2.70267915411201e-22
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40042,-0.11966505512328,0.00521628889024907,-0.129888981348168,-0.109441128898392,1.43028249351006e-114
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40042,-0.00955788699947859,0.00488930171620197,-0.0191409183632345,2.51443642772711e-05,0.0506177644336827
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40042,-0.145231291511862,0.00516252083013712,-0.15534983233893,-0.135112750684793,6.79164872996323e-170
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40042,0.0871529344693075,0.00522179869917758,0.0769182090189195,0.0973876599196956,5.32840556719629e-62
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40042,-0.0300581741380183,0.00475875854636185,-0.0393853408888875,-0.0207310073871491,2.75001946362725e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40042,-0.033017246555677,0.00490112266522256,-0.0426234469795132,-0.0234110461318408,1.67729866004692e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40042,0.0959985504463519,0.00491144031422981,0.0863721274304614,0.105624973462242,4.52608343111395e-84
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40042,-0.156484602054371,0.00524280776917502,-0.166760505281954,-0.146208698826788,2.05827626423372e-190
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40042,0.0527076810849826,0.00506969812726044,0.0427710727555522,0.0626442894144131,3.1064386624004e-25
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40042,-0.0553116226013024,0.00484623454859932,-0.0648102423165571,-0.0458130028860477,4.72214715100124e-30
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40042,-0.0246844415932465,0.00492520908725659,-0.0343378514042694,-0.0150310317822236,5.44981717710248e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40042,0.0613093399622654,0.00488527493521942,0.0517342010892353,0.0708844788352954,5.94414922945957e-36
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40042,-0.10828166768867,0.00519621704781447,-0.118466253102386,-0.0980970822749533,3.82116355955522e-95
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40042,0.100295496884559,0.00514762818862247,0.0902061456348587,0.110384848134259,1.48132352103058e-83
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40040,-0.129351378102649,0.00551627835701781,-0.140163283682404,-0.118539472522894,1.57125285466993e-119
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40040,0.0433896018798144,0.00558343364358402,0.0324460719383897,0.0543331318212391,8.26190909783615e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40040,-0.103026403588262,0.00555063775386499,-0.113905653585838,-0.0921471535906869,4.37047200303875e-76
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40040,0.210135072510933,0.00571626445998157,0.198931194169369,0.221338950852497,8.68082743544151e-284
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40040,0.157922218465853,0.00544377482219518,0.147252419814351,0.168592017117356,2.94914778089028e-180
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40042,0.124713763632399,0.00573486169042211,0.113473434719172,0.135954092545626,2.53944536925793e-103
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40042,-0.172870938284965,0.00562205233065909,-0.183890160853057,-0.161851715716874,1.26492501390765e-201
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40042,-0.177850460551344,0.00567108464174288,-0.18896578644916,-0.166735134653528,2.08140083230495e-209
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40042,-0.0712641727497997,0.00559605383756529,-0.0822324382714277,-0.0602959072281717,5.79456962032583e-37
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40042,0.165458989072145,0.00545590212013874,0.154765420916673,0.176152557227617,2.45482775469075e-196
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40042,0.220461644347793,0.0051977712056099,0.210274012784797,0.230649275910788,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40042,-0.198289134777744,0.00510842804814353,-0.208301653752106,-0.188276615803383,1.66880565520463e-308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40042,-0.173069646413327,0.00512999357612562,-0.183124433822533,-0.163014859004121,6.96835074443675e-241
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40042,-0.210373842675482,0.00549793384819496,-0.221149793017944,-0.19959789233302,2.87797515719723e-306
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40042,0.167412400348936,0.00502918480441357,0.157555198132285,0.177269602565586,8.69653618208264e-235
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40042,-0.0421462658063225,0.00508243131756589,-0.0521078311887516,-0.0321847004238933,1.19823473513249e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40042,-0.0888650671078724,0.00504923332709186,-0.0987615644289725,-0.0789685697867724,1.14137624581158e-68
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40042,-0.0612963647977504,0.00508913659022772,-0.0712710725145967,-0.0513216570809041,2.91114367549189e-33
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40042,-0.0937342381730621,0.00514394313113101,-0.103816366710079,-0.0836521096360454,1.98557768588973e-73
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40042,0.182536757057439,0.00499393750578809,0.172748639546094,0.192324874568783,1.01402900885464e-280
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51318,0.000163813553048617,0.00434338693515823,-0.00834922483986152,0.00867685194595876,0.969914698104014
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51318,-0.00136135113371332,0.00425384731220397,-0.0096988918656331,0.00697618959820646,0.748949435718456
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49476,-0.0026762564237125,0.00410353609422376,-0.0107191871683911,0.00536667432096608,0.514289124574406
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49476,0.00159478053851983,0.00446204672362276,-0.00715083103978078,0.0103403921168204,0.720787835390395
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49476,-0.00738842889031223,0.0043876676725676,-0.0159882575285447,0.00121139974792026,0.0922119134533021
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49476,-0.00940963367304022,0.00401286901793395,-0.0172748569481908,-0.00154441039788968,0.0190417726844005
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24009.Traffic intensity on the nearest road,51318,-0.12090335490245,0.0419825003319382,-0.203189055553049,-0.0386176542518509,0.00398177218904882
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24010.Inverse distance to the nearest road,51318,-0.00327437199858065,0.00379552572325669,-0.0107136024161638,0.00416485841900248,0.38831419633441
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24011.Traffic intensity on the nearest major road,51318,0.00675857785199341,0.00380480283263297,-0.000698835699967214,0.014215991403954,0.0756901832254476
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24012.Inverse distance to the nearest major road,51318,-0.00878006251842986,0.00386057431769324,-0.0163467881811086,-0.0012133368557511,0.0229564526709281
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24013.Total traffic load on major roads,51318,-0.0440108521078111,0.0286759154123456,-0.100215646316008,0.0121939421003862,0.124852818066658
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24015.Sum of road length of major roads within 100m,51318,-0.064043502939423,0.0279219191187602,-0.118770464412193,-0.00931654146665307,0.0218174838352107
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51318,-0.00407087623934997,0.0043180888713688,-0.0125343304272328,0.00439257794853288,0.345817511390667
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51318,-0.00441999004958716,0.00430850966768949,-0.0128646689982586,0.00402468889908425,0.30495999676753
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51318,-0.00725136594061879,0.00426795294887348,-0.0156165537204108,0.00111382183917322,0.0893257338540285
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51252,-0.000229649636070929,0.00419563696715909,-0.00845309809170275,0.00799379881956089,0.956349718476061
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24020.Average daytime sound level of noise pollution,51318,-0.0111310112321603,0.00382328545756179,-0.0186246507289814,-0.00363737173533917,0.00360139561330732
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24021.Average evening sound level of noise pollution,51318,-0.0110764336750307,0.00382285818828511,-0.0185692357240695,-0.00358363162599189,0.00376547091146353
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24022.Average night-time sound level of noise pollution,51318,-0.0111370688133294,0.00382319613942699,-0.0186305332466063,-0.00364360438005251,0.00358239883314908
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51318,-0.0111765968709999,0.00382297019992484,-0.0186696184628526,-0.0036835752791472,0.00346367284110864
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51318,-0.0111408768928453,0.00382288159437763,-0.0186337248178255,-0.00364802896786516,0.00356825137473416
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48413,-0.000376167293172185,0.00443024122873607,-0.00905944010149488,0.00830710551515051,0.932334456691958
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48413,0.01191826998929,0.0040402382268906,0.00399940306458443,0.0198371369139956,0.00318191417745678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24502.Water percentage, buffer 1000m",48413,-0.00958862724691613,0.00397366094753829,-0.0173770027040912,-0.00180025178974107,0.0158272728818324
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48413,6.84534966702084e-05,0.00417529837152888,-0.00811513131152639,0.00825203830486681,0.986919504520277
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48413,0.0101875778543429,0.00407144724827219,0.00220754124772944,0.0181676144609564,0.0123490057054588
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24505.Water percentage, buffer 300m",48413,-0.00990406318965441,0.00399161155527037,-0.0177276218379843,-0.00208050454132449,0.0131001896056826
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51479,-0.00465262665276171,0.00423649402829052,-0.0129561549482111,0.00365090164268771,0.272115726708455
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51479,-0.00251242635940853,0.00399755657915057,-0.0103476372545436,0.00532278453572659,0.529687974809186
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24508.Distance (Euclidean) to coast,51479,0.00708286987399955,0.00381746431157886,-0.000399360176695015,0.0145650999246941,0.0635520036973204
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35423,0.0381057665941137,0.0301791126697704,-0.0210452942386363,0.0972568274268637,0.206740519355625
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2704.Years since last cervical smear test,45124,0.017213731784494,0.0218614904061525,-0.025634789411565,0.0600622529805529,0.431056929008901
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2714.Age when periods started (menarche),50829,0.012887559891251,0.0186099043558106,-0.0235878526461377,0.0493629724286398,0.488622697956265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2734.Number of live births,51645,0.034008088935265,0.0179845186363406,-0.00124156759196248,0.0692577454624925,0.0586396863752758
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2744.Birth weight of first child,46028,-0.0764745900042169,0.0200160509528524,-0.115706049871808,-0.0372431301366262,0.000133466446827575
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2754.Age at first live birth,42835,-0.0295402107723786,0.00484158085971817,-0.0390297092574262,-0.020050712287331,1.0727749793436e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2764.Age at last live birth,42783,-0.0179252918264715,0.0046733720658958,-0.0270851010756273,-0.00876548257731571,0.000125665938624213
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2794.Age started oral contraceptive pill,45295,-0.00269429387821481,0.00525885966624662,-0.0130016588240582,0.00761307106762857,0.608422533352528
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2804.Age when last used oral contraceptive pill,43355,-0.00372123392822121,0.00453675936591677,-0.0126132822854181,0.00517081442897566,0.412089341082437
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2867.Age started smoking in former smokers,29976,-0.0227978931849161,0.00881613546461722,-0.0400775186955659,-0.0055182676742664,0.00973707721844692
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35380,-0.0049550901328792,0.0332557573160991,-0.0701363744724335,0.0602261942066751,0.881556802994255
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35374,-0.01248563460958,0.0360473997434464,-0.0831385381067348,0.0581672688875749,0.729073493330704
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35411,-0.00820302204060617,0.0393445910579977,-0.0853184205142816,0.0689123764330692,0.834848910966919
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35368,0.019333264030506,0.0375838879719833,-0.0543311563945813,0.0929976844555933,0.606980690890987
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28739.Difficulty with standing for long periods,35421,0.0682669450201552,0.0332147787923541,0.00316597858714104,0.133367911453169,0.0398718941100576
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28740.Difficulty with taking care of household responsibilities,35451,0.0669802209733447,0.0358242826246208,-0.00323537297091205,0.137195814917602,0.06155375133167
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28741.Difficulty learning a new task,35343,0.0675813673305505,0.0397709468679883,-0.0103696885307066,0.145532423191808,0.0892978807037057
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28742.Difficulty with joining in community activities,35060,-0.0135536608175507,0.0422101779229752,-0.0962856095465821,0.0691782879114806,0.748141428148464
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28743.Difficulty with being emotionally affected by health problems,35374,0.0459612206011877,0.0351249948675745,-0.0228837693392584,0.114806210541634,0.190729725426378
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35444,0.057991639010824,0.0513369447388926,-0.0426287726774056,0.158612050699054,0.258657756298936
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29946,0.081093595374069,0.0406044696163935,0.00150883492593772,0.1606783558222,0.0458571243804046
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2897.Age stopped smoking,29986,0.0660863202619241,0.00898644139528308,0.0484728951271693,0.083699745396679,2.20395808884959e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34313,-0.0108589434235514,0.0124856699224639,-0.0353308564715806,0.0136129696244777,0.384478698617665
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34313,0.0138400640732287,0.0133008021006518,-0.0122295080440488,0.0399096361905062,0.298112944772458
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34313,-0.0228756739069402,0.0445621520686871,-0.110217491961567,0.0644661441476865,0.607722830919818
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34313,-0.0250757891921441,0.0465593695982425,-0.116332153604699,0.0661805752204112,0.590191161436233
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34313,0.0570068551987212,0.0489329747162595,-0.0389017752451474,0.15291548564259,0.244047673019089
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34313,-0.0215355625348885,0.0404472949093378,-0.100812260557191,0.0577411354874135,0.594436624979129
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34313,0.0319223670113228,0.0187477387249745,-0.00482320088962724,0.0686679349122728,0.088649824726106
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34313,-0.0152087731751538,0.0333369724085328,-0.0805492390958781,0.0501316927455704,0.648246585120002
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29002.Recent lack of interest or pleasure in doing things,34238,0.0171993560937563,0.0401117409894069,-0.0614196562454812,0.0958183684329938,0.668088351512491
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29003.Recent feelings of depression,34221,0.00310152985401016,0.03829040708064,-0.0719476680240443,0.0781507277320646,0.935443469245263
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34241,0.0576600487790965,0.0318080796074579,-0.00468378725152099,0.120003884809714,0.0699012442176392
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29005.Recent feelings of tiredness or low energy,34248,0.0869617751006657,0.0322335913728673,0.0237839360098458,0.150139614191486,0.00699059562123624
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29006.Recent poor appetite or overeating,34257,0.0444822094727347,0.0411015704100932,-0.0360768685310479,0.125041287476517,0.279167699808131
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29007.Recent feelings of inadequacy,34211,-0.0279859968427067,0.0415817899568663,-0.109486305158165,0.0535143114727513,0.500941012875518
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29008.Recent trouble concentrating on things,34257,0.0362659236220447,0.0415980913944936,-0.0452663355111627,0.117798182755252,0.383329565017921
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34244,0.0899887249343259,0.0729217109628401,-0.0529378285528406,0.232915278421492,0.217215492693044
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29010.Recent thoughts of suicide or self-harm,34179,-0.0151472139657479,0.0835521706367939,-0.178909468413864,0.148615040482368,0.85614334817653
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29038#0.Substances taken for depression_None of options listed,32973,-0.0238964332604912,0.0248483796421765,-0.0725992573591571,0.0248063908381747,0.336232735858408
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32973,-0.123499351755886,0.0494605484037671,-0.220442026627269,-0.0265566768845024,0.0125462219599082
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32973,0.0113287726249116,0.0232765970427394,-0.0342933575788577,0.0569509028286809,0.62648185413462
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32973,-0.0318101318828321,0.0661037394488025,-0.161373461202485,0.0977531974368208,0.630375832843002
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32973,-0.0394171712673653,0.0423483097491089,-0.122419858375619,0.0435855158408882,0.351991162169606
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32973,-0.0215452141412242,0.0443327774384727,-0.108437457920631,0.0653470296381823,0.626987910330862
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32973,-0.0167914944775184,0.0509451149667631,-0.116643919812374,0.0830609308573372,0.741710552822888
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32973,0.0523739253859904,0.0598135662108512,-0.0648606643872779,0.169608515159259,0.381261598253414
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32973,0.0130672986604702,0.0450728875406307,-0.075275560919166,0.101410158240106,0.771888447964574
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32973,-0.0109351603531965,0.0250210265243481,-0.0599763723409187,0.0381060516345256,0.662094257075474
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32973,0.0256919093171162,0.0375016225931415,-0.047811270965441,0.0991950895996735,0.493307066010194
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32973,-0.0250550313865414,0.0583472306514634,-0.13941560346341,0.0893055406903269,0.667633900679634
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32973,-0.0288913078434715,0.0771115804693206,-0.18003000556334,0.122247389876397,0.707916078997191
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32973,-0.0774915932976457,0.0501322585342956,-0.175750820024865,0.0207676334295736,0.122203757050029
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32973,0.0617839540137309,0.0851274608471854,-0.105065869246753,0.228633777274214,0.467992534682213
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32973,-0.0605713071598073,0.0807846015135346,-0.218909126126335,0.0977665118067204,0.45340322883431
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32973,-0.0865594308913615,0.043008080526584,-0.170855268723466,-0.00226359305925691,0.0441847784349139
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32973,-0.00890332269106783,0.0427527243376194,-0.0926986623928018,0.0748920170106662,0.835037508123634
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32973,0.0305973682089046,0.0583452589121789,-0.083759339258966,0.144954075676775,0.600000715571448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29058.Recent feelings or nervousness or anxiety,34102,-0.0103403161327333,0.0357803044762819,-0.0804697129062458,0.0597890806407792,0.772591690057072
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29059.Recent inability to stop or control worrying,34114,0.0402171451890448,0.0365785806848705,-0.0314768729533013,0.111911163331391,0.271589402664635
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29060.Recent worrying too much about different things,34107,-0.0102532274111611,0.0343933814628811,-0.0776642550784081,0.057157800256086,0.765620822238022
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29061.Recent trouble relaxing,34111,0.0126968196121205,0.0361871153699485,-0.0582299265129785,0.0836235657372195,0.725696716095779
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29062.Recent restlessness,34122,0.0319493471253413,0.0521406298298628,-0.0702462873411899,0.134144981591872,0.540053833955446
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29063.Recent easy annoyance or irritability,34089,-0.0181305453441918,0.0381013766209074,-0.0928092435211704,0.0565481528327868,0.63419193551779
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29064.Recent feelings of foreboding,34078,0.0499016685642471,0.0408243705071564,-0.0301140976297794,0.129917434758274,0.221605240479478
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32973,-0.0135183564823239,0.0242442124973624,-0.0610370129771542,0.0340003000125064,0.577138300341703
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32973,0.0531966841777399,0.0426506648332211,-0.0303986188953735,0.136791987250853,0.212334602248256
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32973,-0.0497833446604209,0.0528448888135474,-0.153359326734974,0.0537926374141319,0.346185832308249
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32973,0.083564867567283,0.0585734480427261,-0.0312390905964602,0.198368825731026,0.153712234242839
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#2.Symptoms of panic attack_Sweating,32973,0.0176205733710456,0.0400804827555556,-0.0609371728298435,0.0961783195719346,0.660216425467724
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32973,0.00901866687839704,0.0393530296375817,-0.068113271211263,0.0861506049680571,0.818739660589101
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32973,-0.00314690145544609,0.040437093312572,-0.0824036043480873,0.0761098014371951,0.93797135564902
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32973,0.0258940071135504,0.0362952421110126,-0.0452446674240343,0.0970326816511352,0.475601084672257
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32973,-0.016862072740131,0.0497699920635927,-0.114411257184773,0.0806871117045107,0.734768758101723
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29076.Felt loved as a child,34079,0.0117114179195225,0.033437516304171,-0.0538261140366526,0.0772489498756977,0.726160370201592
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29077.Physically abused by family as a child,34093,-0.051250071570711,0.0471455128209596,-0.143655276699792,0.0411551335583698,0.277036818985311
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29078.Felt hated by family member as a child,34073,0.0210573927907011,0.0434107433944605,-0.0640276642624416,0.106142449843844,0.627635394816558
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29079.Sexually molested as a child,33966,0.032508826991979,0.0556234322999235,-0.0765131003158709,0.141530754299829,0.558934940509507
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29080.Someone to take to doctor when needed as a child,34047,-0.0606896425610158,0.046801522691483,-0.152420627036322,0.0310413419142909,0.194750118462348
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34076,0.0777093756381132,0.0565982991318216,-0.0332232906602571,0.188642041936483,0.169784828080714
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29082.Belittlement by partner or ex-partner as an adult,33996,0.0868448597234436,0.0429843820647535,0.00259547087652671,0.171094248570361,0.043371688621691
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34074,-0.0184320451230699,0.0489966813449546,-0.114465540559181,0.0776014503130412,0.706784193422896
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34035,0.00887740180267915,0.0597243561769736,-0.108182336304189,0.125937139909547,0.881841186137855
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34040,-0.00351907405394524,0.0599785421988722,-0.121077016763735,0.114038868655844,0.953214411522289
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29086.Experienced a violent or sexual assault,34070,-0.0386207268694122,0.0565512420915684,-0.149461161368886,0.0722197076300619,0.494665436001548
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29087.Experienced a life-threatening injury or illness,34081,0.0718097335148703,0.0401541902138218,-0.00689247930422043,0.150511946333961,0.073751040958812
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29088.Experienced a marital separation or divorce,34088,0.0157901939771997,0.0358207048375307,-0.0544183875043605,0.0859987754587598,0.659359047262024
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29089.Experienced the death of a spouse or partner,34096,0.0248286664435317,0.0455498074650335,-0.0644489561879339,0.114106289074997,0.585705405666707
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34080,-0.101846801472863,0.0462887577319919,-0.192572766627567,-0.0111208363181586,0.0278128890020027
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29091.Frequency of drinking alcohol,34095,-0.311997690107096,0.0303678498361063,-0.371518675785865,-0.252476704428328,1.23695819245936e-24
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,32861,-0.260885302300112,0.038086536114593,-0.335534913084715,-0.18623569151551,7.91539829087262e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,32875,-0.256496622448003,0.0389129070192913,-0.332765920205814,-0.180227324690192,4.61417342792157e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29104.Ever used cannabis,34088,-0.0661027945642463,0.0457485046455745,-0.155769863669572,0.0235642745410798,0.148513712238395
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29108.Ever thought that life not worth living,34034,0.0598743879456154,0.0360619230963679,-0.0108069813232657,0.130555757214497,0.0968825066483532
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29109.Ever contemplated self-harm,34070,0.0658318418047565,0.0471013836107206,-0.0264868700722559,0.158150553681769,0.162246651784782
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29111.Ever self-harmed,34085,0.144335555434485,0.0717766120579407,0.00365339580092111,0.285017715068049,0.0443638828853692
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34079,0.00887992502706822,0.0509398604107637,-0.0909622013780287,0.108722051432165,0.861616281836115
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33664,0.0349399226004875,0.0533176259207325,-0.0695626242041482,0.139442469405123,0.512280332022491
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33664,0.0718157213496112,0.0408853202841239,-0.00831950640727168,0.151950949106494,0.0790335557101415
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33664,0.0949367471414873,0.041192039534197,0.0142003496544611,0.175673144628513,0.0212035304203073
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33664,0.0693925587033327,0.0536018534054517,-0.0356670739713526,0.174452191378018,0.195493281230581
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34073,-0.0637784041682447,0.0336920025693263,-0.129814729204124,0.00225792086763488,0.0583900534127177
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X29153.Pain or discomfort today,34086,0.0239312288723667,0.0323435465435197,-0.0394621223529318,0.0873245800976653,0.459374229457083
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29154.Anxiety or depression today,34086,0.0282339008450746,0.038447831800259,-0.047123849483433,0.103591651173582,0.462757520256659
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29166.Frequency of confiding in someone close,33848,-0.0256369175367883,0.0310026951392168,-0.0864022000096533,0.0351283649360767,0.40830032707038
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34052,0.0156543403680645,0.0133571290322598,-0.0105256325351647,0.0418343132712938,0.241232598368661
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34052,-0.0378429227624526,0.0130827653801549,-0.0634851429075562,-0.0122007026173491,0.00382952726107959
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34052,-0.0493465571179365,0.0191154339717895,-0.0868128077026438,-0.0118803065332292,0.00985179166486431
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34052,0.0506219227325841,0.0167200876507406,0.0178505509371324,0.0833932945280357,0.0024714931585357
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34052,-0.0255509008179751,0.0248835658875359,-0.0743226899575455,0.0232208883215954,0.304531901892404
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34052,0.00273078576190239,0.0131100284590215,-0.0229648700177797,0.0284264415415845,0.835001125707525
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34052,0.0110257094395268,0.0145939888068552,-0.0175785086219095,0.0396299275009631,0.449969585899509
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34052,-0.0189289473799188,0.0204445003072297,-0.059000167982089,0.0211422732222514,0.354536871334909
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34052,-0.0422968037183581,0.0421595521279191,-0.124929525889079,0.0403359184523632,0.315762874121626
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34052,0.0702723063970725,0.0280215567457465,0.0153500551754094,0.125194557618736,0.0121650987215964
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34052,-0.0300757582979351,0.039182691146751,-0.106873832945567,0.0467223163496968,0.442757018138708
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34052,-0.00453142345110485,0.0208274347612576,-0.0453531955831697,0.03629034868096,0.82776884221028
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29171.Frequency of feeling 'in tune' with people,33943,-0.0169179146077146,0.0390181078323992,-0.0933934059592171,0.0595575767437879,0.664595062416187
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29172.Freuency of feeling that lacks companionship,34026,0.0364037391499567,0.034996241607492,-0.0321888944007276,0.104996372700641,0.298264653202497
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29173.Frequency of feeling left out,33967,0.0200618760747774,0.0363700607852621,-0.0512234430643364,0.0913471952138911,0.581232554721678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29174.Frequency of feeling isolated from others,33998,0.0337270944720973,0.0378368547757758,-0.0404331408884232,0.107887329832618,0.372746694520467
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29175.Tendency to bounce back quickly after hard times,34071,-0.0397222565330392,0.0316547991339563,-0.101765662835593,0.0223211497695151,0.209561055314085
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29176.Ability to make it through stressful events,34071,0.0198939675557898,0.030921965283921,-0.0407130844006955,0.080501019512275,0.52000562267432
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29177.Quick recovery from stressful events,34071,-0.00771530283323415,0.0313852334292927,-0.0692303603546479,0.0537997546881796,0.805822263712255
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29178.Hard to snap back when something bad happens,34071,-0.0014647341254684,0.0309130139776615,-0.0620542415216849,0.0591247732707481,0.962209405663435
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29179.Comes through difficult times with little trouble,34071,-0.00995715645719893,0.031304036311668,-0.0713130676280681,0.0513987547136703,0.750431922435829
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29180.Tendency to take a long time to get over setbacks,34071,-0.00837513533011596,0.0312815085815757,-0.0696868921500044,0.0529366214897725,0.788909525842002
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29181.General happiness,34015,0.0747170311958563,0.0326072057020695,0.0108069080198001,0.138627154371913,0.0219603772268927
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29182.Belief that own life is meaningful,33917,-0.00960166738620058,0.0321156036630941,-0.072548250565865,0.0533449157934638,0.764967948845303
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,29538,0.0972853603234508,0.041948184454769,0.0150669187921035,0.179503801854798,0.020424747843073
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2946.Father's age,30619,-0.00400954003777032,0.011977284673142,-0.0274850179971287,0.0194659379215881,0.737815995892867
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2966.Age high blood pressure diagnosed,30248,-0.013808009950234,0.00922167685367482,-0.0318824965834367,0.00426647668296863,0.134358578882482
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30000.White blood cell (leukocyte) count,50753,0.184736792911554,0.003832275555654,0.177225532822472,0.192248053000636,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50753,0.0177241107405773,0.00468200365022287,0.00854738358614044,0.0269008378950141,0.000153689456722424
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30020.Haemoglobin concentration,50753,-0.0333811992898761,0.00508612997646629,-0.04335001404375,-0.0234123845360022,5.36509409560894e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30030.Haematocrit percentage,50753,-0.021403290304585,0.00493536648483884,-0.0310766086148692,-0.0117299719943009,1.45164046492803e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30040.Mean corpuscular volume,50753,-0.0482477008746048,0.00391087057357542,-0.0559130071988126,-0.040582394550397,7.16564255747237e-35
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50752,-0.0532333021675165,0.00391827628110914,-0.0609131236784904,-0.0455534806565426,6.7255687033583e-42
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50752,-0.0214617891074164,0.00384644811334481,-0.0290008274095722,-0.0139227508052606,2.43390417499466e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50753,0.00802784195258211,0.00371686010587075,0.000742796145075447,0.0153128877600888,0.030793672413453
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30080.Platelet count,50753,0.175247998674657,0.00378878382880772,0.167821982370194,0.18267401497912,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30090.Platelet crit,50753,0.171071359836353,0.00389808646578512,0.163431110363414,0.178711609309292,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50753,-0.0608875331066995,0.00379344274199981,-0.0683226808810191,-0.0534523853323799,1.06248990429995e-57
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30110.Platelet distribution width,50753,-0.0291034903821389,0.00380136639543541,-0.0365541685171923,-0.0216528122470855,1.98297731008641e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30120.Lymphocyte count,50714,0.204890086895441,0.00377022164238126,0.197500452476373,0.212279721314508,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30130.Monocyte count,50714,0.102791800078279,0.00398038852385549,0.0949902385715223,0.110593361585036,3.05960485302974e-145
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30140.Neutrophill count,50714,0.116440724772682,0.00390238467922361,0.108792050801404,0.124089398743961,2.02642540238753e-192
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30150.Eosinophill count,50714,0.0910488631024442,0.00386592770162514,0.0834716448072589,0.0986260813976295,2.19301506095854e-121
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30160.Basophill count,50714,0.305179411670643,0.0208974627803534,0.26422038462115,0.346138438720135,4.11095891305763e-48
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30170.Nucleated red blood cell count,50714,0.251673394840502,0.0849856119031139,0.0851015955103982,0.418245194170605,0.00306552973118402
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30180.Lymphocyte percentage,50714,0.0655156755225766,0.00390378453540067,0.0578642578331913,0.0731670932119619,6.96175512337046e-63
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30190.Monocyte percentage,50714,-0.0318940397135043,0.00396985600935117,-0.0396749574918326,-0.024113121935176,9.82317475693648e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30200.Neutrophill percentage,50714,-0.0543583067860242,0.0038745732842701,-0.0619524704231936,-0.0467641431488548,1.49046802770798e-44
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30210.Eosinophill percentage,50714,0.0318658180812753,0.00385795053255349,0.0243042350374705,0.0394274011250802,1.52739557515342e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30220.Basophill percentage,50714,-0.0137329443277824,0.00369974344455691,-0.020984441479114,-0.0064814471764509,0.000206163400765051
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30230.Nucleated red blood cell percentage,50714,0.246500399032696,0.0850558804079441,0.0797908734331251,0.413209924632266,0.00375742022722083
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30240.Reticulocyte percentage,50281,0.033537144217186,0.0040490062290838,0.0256010920081818,0.0414731964261903,1.26066674953315e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30250.Reticulocyte count,50281,0.0372676779848933,0.0041828578698192,0.0290692765600476,0.0454660794097389,5.45040680523124e-19
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30260.Mean reticulocyte volume,50281,-0.0370582216344603,0.00387659609891947,-0.0446563499883425,-0.0294600932805782,1.2852121969326e-21
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30270.Mean sphered cell volume,50281,-0.0478164964830974,0.00391468366104341,-0.0554892764587425,-0.0401437165074524,3.2268822547406e-34
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30280.Immature reticulocyte fraction,50281,0.0284737679341972,0.00409489904859723,0.0204477657989467,0.0364997700694478,3.64886670804848e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50281,0.0382232369555712,0.00416012739939297,0.0300693872527609,0.0463770866583814,4.29438519603011e-20
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30300.High light scatter reticulocyte count,50281,0.0411223708399985,0.00426523732418611,0.0327625056845938,0.0494822359954033,5.82739009983068e-22
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30500.Microalbumin in urine,32038,0.0218283210912836,0.00767162548836486,0.00679193513408849,0.0368647070484787,0.00444840476008728
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50800,0.0238296535199337,0.0040830373222662,0.015826900368292,0.0318324066715755,5.40115659076608e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30520.Potassium in urine,50746,-0.00306396366561096,0.00380402272429601,-0.0105198482052311,0.00439192087400922,0.420565275367042
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30530.Sodium in urine,50720,0.00550294041807076,0.0040035848073914,-0.00234408580441639,0.0133499666405579,0.169297220684844
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30600.Albumin,48047,-0.0631344792638684,0.00417108982523334,-0.0713098153213258,-0.0549591432064111,1.63174655647272e-51
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30610.Alkaline phosphatase,50379,0.0561040507506642,0.00395528958364783,0.0483516831667144,0.0638564183346139,1.69006735087245e-45
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30620.Alanine aminotransferase,50388,0.0233429554862374,0.00413987174972471,0.0152288068567769,0.0314571041156978,1.73250640088298e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30630.Apolipoprotein A,47835,-0.222476607823562,0.00435897319006,-0.231020195276079,-0.213933020371044,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30640.Apolipoprotein B,50285,0.0556476027979794,0.00393191407410775,0.0479410512127282,0.0633541543832306,2.65094011407967e-45
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30650.Aspartate aminotransferase,50309,-0.0057544087714056,0.00400467294398,-0.0136035677416064,0.00209475019879519,0.150751823659372
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30660.Direct bilirubin,44625,-0.0484264022005304,0.00448534882874965,-0.0572176859048797,-0.0396351184961811,4.23752044273661e-27
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30670.Urea,50373,-0.000746931781407791,0.00412437342953926,-0.00883070370330473,0.00733684014048915,0.856289025000375
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30680.Calcium,48053,0.00167191733347454,0.00401405843853766,-0.00619563720605928,0.00953947187300836,0.677036656295597
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30690.Cholesterol,50387,-0.0187456878793531,0.00406317390675095,-0.026709508736585,-0.0107818670221213,3.97725854330245e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30700.Creatinine,50380,0.00523487777587605,0.0045051043752768,-0.00359512679966648,0.0140648823514186,0.245250985455843
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30710.C-reactive protein,50324,0.0913964156437853,0.00431629028652335,0.0829364866821995,0.0998563446053711,1.12332649265916e-98
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30720.Cystatin C,50385,0.0693090479256109,0.00440593292681594,0.0606734193890517,0.0779446764621702,1.67927718319828e-55
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30730.Gamma glutamyltransferase,50383,0.0322146717374848,0.00405482590623154,0.024267212961271,0.0401621305136986,2.02396095119263e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30740.Glucose,48027,0.00449043709487465,0.00434105588928263,-0.00401803244811932,0.0129989066378686,0.30095455294359
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50209,0.0899769877337751,0.00437741360684656,0.0813972570643559,0.0985567184031944,3.89889780800011e-93
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30760.HDL cholesterol,48039,-0.256959756162851,0.00454595429329188,-0.265869826577703,-0.248049685747999,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30770.IGF-1,50245,-0.0108966123736632,0.00397427923503467,-0.0186861996743312,-0.00310702507299529,0.00611487556622114
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30780.LDL direct,50334,0.033339247495731,0.00395816205738201,0.0255812498632623,0.0410972451281998,3.86028805550888e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30790.Lipoprotein A,45221,-0.0126605532617984,0.00433811806004025,-0.0211632646594773,-0.00415784186411952,0.00352160754209043
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30810.Phosphate,48007,0.0444211788063694,0.00431220422387901,0.0359692585275666,0.0528730990851723,7.85124986364967e-25
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30830.SHBG,47784,-0.0759143464717338,0.00452809682961632,-0.0847894162577818,-0.0670392766856858,1.02203417733506e-62
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30840.Total bilirubin,50291,-0.0759660733529354,0.00396546927311344,-0.0837383931282378,-0.0681937535776331,3.10445558421645e-81
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30850.Testosterone,45962,-0.00527124123038385,0.00705504788130935,-0.0190991350777502,0.00855665261698248,0.454975866887747
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30860.Total protein,48044,0.0223836158575865,0.00409131469436224,0.0143646390566365,0.0304025926585365,4.52030504356191e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30870.Triglycerides,50377,0.163064301029107,0.00428726664852739,0.154661258397994,0.171467343660221,4.50180216456487e-308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30880.Urate,50351,0.0439998342460744,0.00484098876067462,0.0345114962751522,0.0534881722169967,1.06896883678253e-19
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30890.Vitamin D,48871,-0.0249432148168064,0.00433591489734524,-0.0334416080156031,-0.0164448216180097,8.88784603569028e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X3137.Number of measurements made,49279,0.0272001755995154,0.0229114950108526,-0.0177063546217557,0.0721067058207866,0.235166146325488
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X3143.Ankle spacing width,39882,0.00653740381325238,0.00686081116925538,-0.00690978607848816,0.0199845937049929,0.340675101941988
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39881,0.00376918922455157,0.00556545578817207,-0.00713910412026569,0.0146774825693688,0.498259293355939
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X3146.Speed of sound through heel,39882,-0.011318331542674,0.00536980884237816,-0.0218431568737352,-0.0007935062116128,0.0350668211473927
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39882,-0.00641565682928301,0.00543758141721377,-0.017073316407022,0.00424200274845598,0.23806882255567
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X3148.Heel bone mineral density (BMD),39880,-0.00643852110300611,0.00542388048653764,-0.0170693268566199,0.00419228465060767,0.235218629960012
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X3526.Mother's age at death,40598,-0.00932771662228016,0.00516810364494538,-0.0194571997663731,0.000801766521812776,0.0711148197136757
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X3581.Age at menopause (last menstrual period),39978,-0.00306080337498772,0.00503633709060755,-0.0129320240725785,0.00681041732260307,0.543366200657808
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30081,-0.0027901339376212,0.0086177411742302,-0.0196809066391124,0.01410063876387,0.746127020767485
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4100.Ankle spacing width (left),33198,0.0124055313425891,0.00898587119169858,-0.00520677619314009,0.0300178388783183,0.167449671864871
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4101.Heel broadband ultrasound attenuation (left),33196,-0.00729026439633087,0.00734796657575492,-0.0216922788848105,0.00711175009214877,0.321153182919174
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4103.Speed of sound through heel (left),33198,-0.0176060239791255,0.00715099295755557,-0.0316219701759344,-0.00359007778231659,0.0138341096405957
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",33198,-0.0145043804373543,0.00721298290719499,-0.0286418269354565,-0.000366933939252143,0.0443696818960979
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4105.Heel bone mineral density (BMD) (left),33196,-0.0146996569115328,0.00719234006311002,-0.0287966434352285,-0.000602670387837196,0.0410038652230555
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",33198,-0.0145146974681749,0.00721258038171682,-0.0286513550163399,-0.000378039920009969,0.04420691512502
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4119.Ankle spacing width (right),33199,0.00803826102545645,0.00886533185699953,-0.00933778941426263,0.0254143114651755,0.364586583733038
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4120.Heel broadband ultrasound attenuation (right),33199,-0.001949400953599,0.00735056089327434,-0.0163565003044167,0.0124576983972187,0.790858269404241
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4122.Speed of sound through heel (right),33199,-0.0114380513808195,0.00719020920245292,-0.0255308614176273,0.00265475865598819,0.111694908080691
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",33199,-0.00860422803966062,0.0072394187999768,-0.0227934888876151,0.0055850328082939,0.234659022530839
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4124.Heel bone mineral density (BMD) (right),33196,-0.00869083377652829,0.00722550749767594,-0.0228528284719731,0.00547116091891655,0.229086647954378
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",33199,-0.00860235914282806,0.00723941959563253,-0.0227916215502678,0.0055869032646117,0.234760728173685
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4194.Pulse rate,33459,0.0330950737786879,0.00699526660996562,0.0193843512231553,0.0468057963342206,2.26741835326345e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4195.Pulse wave reflection index,33459,-0.00788670733632489,0.00701797136819258,-0.0216419312179823,0.00586851654533256,0.261133206211067
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4196.Pulse wave peak to peak time,33456,-0.0202997893125263,0.00641481094984515,-0.0328728187742228,-0.00772675985082983,0.0015585675933392
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4198.Position of the pulse wave peak,33459,0.00657601034129543,0.00620374378380263,-0.00558332747495772,0.0187353481575486,0.289169948238852
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4199.Position of pulse wave notch,33459,0.012827758273222,0.00690863049287697,-0.000713157492816875,0.0263686740392609,0.0633760880173702
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4200.Position of the shoulder on the pulse waveform,33459,0.0190712441403296,0.0061949307630593,0.00692917984473341,0.0312133084359259,0.00208654223297364
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4269.Number of triplets attempted (left),33364,-0.0286304705258074,0.0998168649983936,-0.224271525922659,0.167010584871044,0.774249176053393
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4270.Volume level set by participant (left),33273,0.0266029777778856,0.0313162857395881,-0.0347769422717071,0.0879828978274783,0.395629868095592
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4276.Number of triplets attempted (right),33361,-0.0721886895615874,0.0958611475302383,-0.260076538720854,0.11569915959768,0.451436960307717
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4277.Volume level set by participant (right),33254,0.0313728089876509,0.0314269040603942,-0.0302239229707218,0.0929695409460237,0.318171683968017
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X4288.Time to answer,33535,0.0101029854221933,0.00782545334009475,-0.00523490312439243,0.025440873968779,0.196722126641667
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X4290.Duration screen displayed,33535,0.00646705194321083,0.00697311070420175,-0.0072002450370246,0.0201343489234463,0.353729460440277
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X46.Hand grip strength (left),51564,-0.0436564259349394,0.00578333937503521,-0.0549917711100084,-0.0323210807598704,4.53600188687394e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X47.Hand grip strength (right),51565,-0.0377618963427139,0.00576103502083874,-0.0490535249835579,-0.02647026770187,5.67517424815201e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X48.Waist circumference,51651,0.11336907470564,0.00768429863508807,0.0983078493808674,0.128430300030413,4.53336549964483e-49
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X4803.Tinnitus,33375,0.0530901416911135,0.0381594988202297,-0.0217024759965368,0.127882759378764,0.164178457492333
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X4825.Noisy workplace,33507,0.0114532295303339,0.0543137337091973,-0.0950016885396927,0.117908147600361,0.832992131378148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X4836.Loud music exposure frequency,33454,0.0501775238487625,0.0615532255637767,-0.0704667982562398,0.170821845953765,0.414985598175958
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X49.Hip circumference,51648,-0.0385529330113099,0.00654244100612839,-0.0513761173833216,-0.0257297486392983,3.84305767590421e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X50.Standing height,51645,-0.0217370711519569,0.00535846445887581,-0.0322396614913535,-0.0112344808125603,4.99341325460957e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X5057.Number of older siblings,32456,0.0729427512793226,0.0339615765187449,0.00637806130258262,0.139507441256063,0.0317593997522689
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X51.Seated height,51522,-0.0128598127681572,0.005349955246984,-0.0233457250522459,-0.00237390048406858,0.0162357258823137
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5181.Ever had eye surgery,30580,-0.0427327274497829,0.0770225271725128,-0.193696880707908,0.108231425808342,0.579046132728448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5186.Duration visual-acuity screen displayed (right),30562,-0.0204254268013531,0.00799806945804773,-0.0361016429391266,-0.00474921066357952,0.0106796711720804
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5188.Duration visual-acuity screen displayed (left),30564,-0.0189888799908599,0.00791479870332614,-0.0345018854493792,-0.00347587453234069,0.0164624307814247
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5190.Duration at which refractometer first shown (right),30491,-0.0221057128871915,0.00799779876398655,-0.0377813984646051,-0.00643002730977785,0.00572750956978499
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5193.Duration at which refractometer first shown (left),30492,-0.0186554785556585,0.00804601845348913,-0.0344256747244972,-0.00288528238681978,0.020450085758006
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5199.logMAR, initial (right)",30544,0.00705127874086173,0.0403583701279993,-0.0720511267100169,0.0861536841917403,0.861308100626827
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5200.Final number of letters displayed (right),30544,-0.308340392521962,0.255949565905041,-0.810001541695841,0.193320756651918,0.228369041915569
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5201.logMAR, final (right)",30495,-0.00202758073268389,0.00833874226683078,-0.0183715155756722,0.0143163541103044,0.807896007053716
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5202.Number of rounds to result (right),30544,0.0323214744516574,0.037891030239515,-0.0419449448177919,0.106587893721107,0.393686670885208
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5206.logMAR, initial (left)",30542,0.0144575912161748,0.040100975595533,-0.0641403209510699,0.0930555033834195,0.718463583939604
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5207.Final number of letters displayed (left),30542,-0.563151968800741,0.181376092015936,-0.918649109151975,-0.207654828449508,0.00191226963555478
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5208.logMAR, final (left)",30479,0.00643424714761989,0.00823688627100634,-0.00971004994355253,0.0225785442387923,0.434744713252032
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5209.Number of rounds to result (left),30540,-0.0177108832357022,0.038281028703342,-0.0927416994942525,0.0573199330228482,0.643628732357342
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",30251,-0.00324746998487861,0.00826188154967901,-0.0194407578222495,0.0129458178524922,0.694284714434638
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",30251,-0.000100117145110962,0.00835470791735094,-0.0164753446631188,0.0162751103728969,0.990439334397622
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5256.Corneal hysteresis (right),30251,0.00251501595366807,0.00825883861780887,-0.0136723077372373,0.0187023396445735,0.76073951096274
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5257.Corneal resistance factor (right),30251,-0.00147051651129129,0.00829137707479074,-0.0177216155778812,0.0147805825552986,0.859235809291982
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",30254,-0.00677552046556,0.00820454840994155,-0.0228564353490454,0.00930539441792544,0.408937375547377
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",30254,-0.00889343020804376,0.00818266207142608,-0.0249314478680389,0.00714458745195135,0.277142641998773
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5264.Corneal hysteresis (left),30254,0.00361698590067412,0.00837505485459527,-0.0127981216143326,0.0200320934156809,0.665847525262721
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5265.Corneal resistance factor (left),30254,-0.00219909034917469,0.00830168570337164,-0.0184703943277831,0.0140722136294337,0.791098338936298
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29846,0.312404611403229,0.16207738843842,-0.00526706993607301,0.630076292742532,0.0539694646327316
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51562,0.0624742509106222,0.0223974071678994,0.0185753328615395,0.106373168959705,0.00528504815050551
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51562,-0.0481909865725911,0.0231599225162552,-0.0935844347044514,-0.00279753844073086,0.037462293720581
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51562,-0.104640271017594,0.0592436324808904,-0.220757790680139,0.011477248644951,0.0773617569703638
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51562,-0.0303551747022883,0.00976849395077791,-0.049501422845813,-0.0112089265587636,0.00188899455867918
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51562,0.0198576211848791,0.00892719247689492,0.0023603239301651,0.0373549184395932,0.0261299397697785
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37009,-0.00750568469175118,0.0110076178726365,-0.0290806157221187,0.0140692463386163,0.495338311792337
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37009,0.00952842673171673,0.0276184601362094,-0.0446037551352537,0.0636606085986871,0.730098570732938
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37009,-0.0173471142754261,0.0215272229666245,-0.0595404712900102,0.0248462427391579,0.420360632121336
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37009,0.0143065916916288,0.0132521967868453,-0.011667714010588,0.0402808973938456,0.28035721172582
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51645,0.00597084080151255,0.018484411975527,-0.0302586066705203,0.0422002882735454,0.746682331516517
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51645,0.00597084080151255,0.018484411975527,-0.0302586066705203,0.0422002882735454,0.746682331516517
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51645,-0.0520620604286041,0.0147605890183632,-0.0809928149045958,-0.0231313059526123,0.000420831414665755
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51645,-0.0550498580005028,0.0231995058451951,-0.100520889457085,-0.00957882654392041,0.0176564673334452
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51645,0.0679330778663509,0.0578229673302607,-0.0453999381009601,0.181266093833662,0.240066648000121
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51645,0.0248044474103834,0.039124235332956,-0.0518790538422105,0.101487948662977,0.526091455832323
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51645,0.148164502899924,0.062888327026238,0.0249033819284976,0.271425623871351,0.0184802870403352
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51562,-0.00595436387029613,0.0118164116894399,-0.0291145307815983,0.017205803041006,0.614331343185053
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51562,0.0510381347379731,0.0197440743031933,0.0123397491037142,0.089736520372232,0.00974349791405828
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51562,0.017974464841758,0.0104836537757195,-0.0025734965586522,0.0385224262421682,0.0864441579256906
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51562,0.0444137260069826,0.0194092875834783,0.00637152234336516,0.0824559296705999,0.0221293550374552
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51562,0.015257265609404,0.0188431922970068,-0.0216753912927293,0.0521899225115373,0.418121774630345
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51562,0.0634997056615627,0.010612307472079,0.0426995830162879,0.0842998283068375,2.21008582161582e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,31722,0.106529019439712,0.0396228320791054,0.0288682685646652,0.184189770314758,0.00719209632698422
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,31722,0.0238162717982154,0.025816094968813,-0.026783274340658,0.0744158179370889,0.356279780824215
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,31722,0.0520101762504769,0.0329699499323168,-0.0126109256168641,0.116631278117818,0.114723471021877
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,31722,-0.0209399400450302,0.0293711262380651,-0.0785073474716378,0.0366274673815775,0.475903886568309
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51556,0.00476138042646502,0.0290835456448388,-0.052242369037419,0.061765129890349,0.869957602194674
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51556,0.0172606712087051,0.0492784827782742,-0.0793251550367122,0.113846497454122,0.726140367055605
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51556,0.0325101529607283,0.0787643218607037,-0.121867917886251,0.186888223807708,0.679791386337671
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51556,-0.00248412345331668,0.0768971202743285,-0.153202479191001,0.148234232284367,0.97422945399119
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51556,-0.0478871476920859,0.024123192719975,-0.095168605423237,-0.000605689960934803,0.04714249744811
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51556,0.0413309839903185,0.0346972430458555,-0.0266756123795582,0.109337580360195,0.233589717736143
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51556,-0.0299064858633189,0.0171332882368567,-0.0634877308075581,0.00367475908092037,0.0809058412671212
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33791,0.0753333599119722,0.0260405811214277,0.0242938209139739,0.12637289890997,0.00382558722619288
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33791,0.0266394167181102,0.0301378094662303,-0.0324306898357012,0.0857095232719216,0.376762079434601
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33791,0.0519981339876666,0.0396599733176802,-0.0257354137149866,0.12973168169032,0.189856702231822
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33791,0.0136831371951921,0.0136376704402351,-0.0130466968676686,0.0404129712580528,0.315725775743417
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37278,0.0184115494031157,0.0133742347599681,-0.00780195072642183,0.0446250495326532,0.168646615778552
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37278,-0.040540889043801,0.0116556830766926,-0.0633860278741185,-0.0176957502134834,0.000506452296718646
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37278,0.0121569508995516,0.0109486930976949,-0.00930248757193032,0.0336163893710335,0.266866315739635
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37278,0.0563551379796066,0.0263174081693735,0.00477301796763448,0.107937257991579,0.0322635205137559
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37278,0.0433984545634526,0.0157592109510453,0.0125104010994038,0.0742865080275014,0.00589822509420337
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37278,0.00557611460924293,0.0183507735058099,-0.0303914014621445,0.0415436306806304,0.761237465580247
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51562,-0.00039647519578983,0.0256982064797956,-0.0507649598961892,0.0499720095046095,0.987690737445699
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51562,0.00444723317814045,0.0165093253706647,-0.0279110445483624,0.0368055109046433,0.787641603937743
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51562,0.0967082290309839,0.064475403221605,-0.0296635612833619,0.22308001934533,0.133645637531771
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51562,-0.0439995394765835,0.0163577980972833,-0.0760608237472589,-0.0119382552059081,0.00715342406125607
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51562,-0.00235963805807661,0.0194959525456305,-0.0405717050475123,0.0358524289313591,0.903666426501228
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51562,-0.000134571622446293,0.022047434716308,-0.04334754366641,0.0430784004215174,0.995130001998762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51562,-0.002091616824903,0.0078036101551555,-0.0173866927290078,0.0132034590792018,0.788676767065171
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28728,0.0236080509446688,0.02652491619812,-0.0283807848036464,0.075596886692984,0.373498221984542
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28728,0.0892797687440204,0.035031694450974,0.0206176476201113,0.157941889867929,0.0108520543600735
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28728,-0.0169620762853031,0.0232956175712653,-0.062621486724983,0.0286973341543769,0.466578120864502
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28728,0.0404954137209814,0.0210474964298418,-0.000757679281508473,0.0817485067234713,0.0544206852223787
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51684,0.0333434585649769,0.00894964648828013,0.0158021514479478,0.0508847656820059,0.000195187950740113
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51684,0.00999602254612275,0.0241425317347215,-0.0373233396539315,0.057315384746177,0.678846596254647
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51684,0.0236673329018658,0.00872602183879671,0.00656433009782425,0.0407703357059074,0.00668659627992506
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51684,0.014287626160012,0.00870259295055704,-0.00276945602307976,0.0313447083431038,0.100649937155158
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51684,0.0500340924976679,0.0125394703227643,0.0254567306650499,0.0746114543302859,6.62103677168985e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51684,-0.0118856146395139,0.0111250749729656,-0.0336907615865266,0.00991953230749876,0.285366425943056
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51684,-0.00744728656887041,0.0093366920068144,-0.0257472029022266,0.0108526297644858,0.42508840356846
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51684,0.113483986633204,0.0253767383129696,0.0637455795397836,0.163222393726625,7.78156635360623e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43202,-0.0468302296687521,0.00938010880970911,-0.0652152429357819,-0.0284452164017222,6.01361585520212e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43202,-0.0073269085832039,0.0103997442522321,-0.0277104073175788,0.013056590151171,0.481112915313388
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43202,0.0200172340462308,0.0104430884354672,-0.00045121928728498,0.0404856873797465,0.0552794749426425
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43202,-0.00216333443215554,0.013416643731115,-0.0284599561451409,0.0241332872808299,0.871904072411045
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43202,0.00436598935714026,0.00945780169563416,-0.0141713019663027,0.0229032806805832,0.644353218614184
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51443,0.00807327940555278,0.00939550992746485,-0.0103419200522783,0.0264884788633839,0.390199226720736
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51443,-0.00923498018363999,0.00756125007492145,-0.024055030330486,0.00558506996320606,0.221961824829175
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51443,0.00374898637958117,0.00827424284699879,-0.0124685296005365,0.0199665023596988,0.65048673489867
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51443,-0.0736760567169084,0.0181735784155799,-0.109296270411445,-0.0380558430223717,5.04859495146932e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51455,-0.032525463542695,0.00854010160104379,-0.0492640626807408,-0.0157868644046491,0.000140089374250299
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51455,-0.0826795146147537,0.0153360868114917,-0.112738244765277,-0.05262078446423,7.05854563787905e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51562,0.000122971252152018,0.00815438894668663,-0.0158596310833538,0.0161055735876578,0.987968167760724
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51562,-0.0260544167699545,0.00925920670692181,-0.0442024619155213,-0.00790637162438776,0.00489807594317744
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51562,-0.0433535634780905,0.0121319058206017,-0.0671320988864698,-0.0195750280697112,0.000352830289401198
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51562,0.00472617177645739,0.0174339089495768,-0.0294442897647131,0.0388966333176279,0.78632328540742
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51562,-0.00835897375452408,0.0180168026073246,-0.0436719068648802,0.0269539593558321,0.64268418484131
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51562,-0.0062062999261058,0.0232767242097001,-0.0518286793771181,0.0394160795249065,0.789755191273895
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39882,-0.00641845566428456,0.0054375744134966,-0.0170761015147379,0.00423919018616878,0.237863537955089
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X864.Number of days or week walked 10+ minutes,51052,-0.0780750121843002,0.0182184687896403,-0.113783211011995,-0.0423668133566053,1.82980022565553e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X874.Duration of walks,47058,-0.00188442954740588,0.0041813745471918,-0.0100799236599018,0.00631106456509006,0.65223009528088
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,49995,-0.0615429947730431,0.0177500539541809,-0.0963331005232375,-0.0267528890228486,0.000526774832115047
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X894.Duration of moderate activity,43939,-0.0508003406944467,0.0218238656642245,-0.0935751173963266,-0.00802556399256678,0.0199359634421215
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X90087.No-wear time bias adjusted average acceleration,30345,-0.0127558083765408,0.00856783658371804,-0.0295487680806281,0.00403715132754658,0.136593144916074
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,49978,-0.0857546581868695,0.0184265970917827,-0.121870788486764,-0.0496385278869754,3.27426685596627e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X914.Duration of vigorous activity,37898,-0.00315531390323461,0.00556807715583948,-0.01406874512868,0.00775811732221078,0.570941565489916
